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ABSTRACT 
 
Objective: To describe cognitive, nutritional and physical functioning status of those 
with diagnosed neurological disorders for at least one year. 
Design:  This is a cross-sectional study. 
Setting: University of Rhode Island’s Speech and Hearing Clinic.  
Participants: Community-dwelling adults living with Parkinson’s disease (PD) or 
acquired brain injury (ABI) for >12 months. 
Main Outcome Measure(s): Cognitive-linguistic status was measured via the 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). 
Nutritional and cardio-metabolic status were measured using the dietary screening tool 
(DST), anthropometrics (height, weight, body mass index (BMI), body composition), 
biochemical (lipid and glucose profile), and clinical (blood pressure) measures.  
Physical activity and functioning were measured via the Physical Activity and 
Disability Survey (PADS), short physical performance battery (SPPB), and the timed 
up and go (TUG) test. 
Results: Twelve participants were assessed (8 PD, 4 ABI).  Participants with PD had 
significantly higher total RBANS scores than participants with ABI (87.1±14.6 vs. 
66.0±12.6, p=0.034, d=2.455). Mean BMI (n=12) was 26.8±3.0kg/m2 and the majority 
of participants were overweight. DST scores indicated 58% (N=7) at possible nutrition 
risk and 25% (N=3) were at nutrition risk. Mean PADS scores (94.9±89.7) indicated 
participants were physically active. A positive correlation was found between general 
activity scores and DST scores (r=0.697, p=0.012). Fifty percent of participants 
  
reported suboptimal SPPB, balance or TUG scores.  Multiple risk factors for 
development of CVD were present in all participants.  
Conclusion:  Deficits in cognition, low dietary quality and physical functioning, 
and cardio-metabolic risk factors are frequently reported in patients with neurological 
disorders. These findings confirmed the presence of cognitive, dietary and physical 
decline in our participant group and support the need for an interdisciplinary team to 
work with patients and caregivers to improve health and prevent further development 
of comorbidities in this population. 
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PREFACE 
This thesis was written to comply with the University of Rhode Island graduate 
school Manuscript Thesis Format. This thesis contains one manuscript: The Nutrition 
and Physical Assessment of Patients with Neurological Disorders. This manuscript 
has been written in a form suitable for publication in Archives of Physical Medicine 
and Rehabilitation.  
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ABSTRACT 
 
Objective: To describe cognitive, nutritional and physical functioning status of those 
with diagnosed neurological disorders for at least one year. 
Design:  This is a cross-sectional study. 
Setting: University of Rhode Island’s Speech and Hearing Clinic.  
Participants: Community-dwelling adults living with Parkinson’s disease (PD) or 
acquired brain injury (ABI) for >12 months. 
Main Outcome Measure(s): Cognitive-linguistic status was measured via the 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). 
Nutritional and cardio-metabolic status were measured using the dietary screening tool 
(DST), anthropometrics (height, weight, body mass index (BMI), body composition), 
biochemical (lipid and glucose profile), and clinical (blood pressure) measures.  
Physical activity and functioning were measured via the Physical Activity and 
Disability Survey (PADS), short physical performance battery (SPPB), and the timed 
up and go (TUG) test. 
Results: Twelve participants were assessed (8 PD, 4 ABI).  Participants with PD had 
significantly higher total RBANS scores than participants with ABI (87.1±14.6 vs. 
66.0±12.6, p=0.034, d=2.455). Mean BMI (n=12) was 26.8±3.0kg/m2 and the majority 
of participants were overweight. DST scores indicated 58% (N=7) at possible nutrition 
risk and 25% (N=3) were at nutrition risk. Mean PADS scores (94.9±89.7) indicated 
participants were physically active. A positive correlation was found between general 
activity scores and DST scores (r=0.697, p=0.012). Fifty percent of participants 
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reported suboptimal SPPB, balance or TUG scores.  Multiple risk factors for 
development of CVD were present in all participants.  
Conclusion:  Deficits in cognition, low dietary quality and physical functioning, 
and cardio-metabolic risk factors exist in patients with neurological disorders. These 
findings confirmed the presence of cognitive, dietary and physical decline in our 
participant group and support the need for an interdisciplinary team to work with 
patients and caregivers to improve health and prevent further development of 
comorbidities in this population. 
Key words: Parkinson’s disease, stroke, traumatic brain injury 
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INTRODUCTION 
Parkinson’s disease (PD), traumatic brain injury (TBI), and stroke are 
neurological disorders that can result in lifelong challenges that impact cognitive, 
physical, and psychosocial functioning1-5, which, in turn, can jeopardize dietary intake 
and increase likelihood of nutritional risk and cardiovascular disease (CVD). 
Parkinson’s disease is a progressive, neurodegenerative, movement disorder affecting 
nearly one million people in the United States6. Traumatic brain injury and stroke are 
types of acquired brain injury (ABI), defined as structural damage to the brain7,8. 
Nearly 2,500,000 people experience a TBI or stroke annually in the United States8,9. 
While these neurological diseases are each unique and have different long-term 
effects, they share similar complications that can negatively impact nutritional status 
and dietary intake, as well as physical function.  
Limited research exists examining the interaction between cognition, 
nutritional status, and physical function for those with PD and ABI one year or more 
after diagnosis. Unintentional weight loss is typical at the time of PD diagnosis and 
nutritional status declines as the disease progresses1. Malnutrition and muscle wasting 
are consistently reported in the acute stages of ABI10-13. Since nutritional status is 
compromised in the acute phase after an ABI, long-term nutritional status is likely to 
be poor13. However, due to a scarcity of research, little is known about the long-term 
nutritional status of those with ABI. Cognitive and physical impairment associated 
with these neurological disorders may contribute to metabolic and nutritional 
imbalances1,3,5,14,15.  
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The cardio-metabolic effect of PD seems to be two-fold, research indicates 
those with PD may have sub-optimal lipid profiles and glucose intolerance16, while 
other research indicates there may be a protective cardio-metabolic effect of PD, even 
in those with PD that are overweight17,18. Cardio-metabolic effects of ABI have been 
less investigated. Those with TBI are at increased risk for significant weight change, 
and diseases related to diet and activity, such as coronary heart disease (CHD) and 
metabolic syndrome3,15.  An obesity paradox seems to exist following stroke12,19. 
Being overweight or obesity increases risk of a first-time stroke, however, those who 
are overweight or obese post-stroke, have better functional outcomes12,19, and are less 
likely to have a reoccurring stroke in the years following stroke20,21.    
Research has yet to examine and describe the long-term status (a year or more 
since diagnosis) of the cognitive, nutritional and physical functioning status across all 
three neurological diagnoses.  The purpose of this cross-sectional study is to describe 
the cognitive function, dietary quality, and physical activity and functioning in those 
living with PD or ABI for a year or more. A secondary aim is to analyze how 
compromised cognition, nutrition and physical activity and functioning increase 
cardiovascular risk in those living with PD or ABI. An exploratory aim is to assess 
differences between PD and ABI across the areas of cognition, nutrition, and physical 
activity.  
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MATERIALS AND METHODS 
Design  
This cross-sectional study is a sub-study of a five-year longitudinal, 
observational study examining the nutritional status, cognitive and physical activity 
levels of those living with neurological disorders, specifically, PD, TBI, and stroke.  
Data used in this study was obtained during baseline assessments through the 
University of Rhode Island (URI)’s Department of Communicative Disorders’ Clinic, 
and included study staff from the Departments of Nutrition and Food Sciences and 
Kinesiology. Study approval was obtained from URI’s Institutional Review Board, 
and written informed consent of all participants was obtained. Two baseline 
assessments were conducted in November and December 2013 at the URI Kingston’s 
Campus Speech and Hearing Clinic.  
Participants, Setting and Recruitment   
For the purposes of this sub-study participants had to be diagnosed with PD, 
TBI or stroke for at least 12 months and be between the ages of 18-85. Participants 
were recruited via brochures and word-of-mouth to clients currently obtaining services 
at the Department of Communicative Disorder’s Speech and Hearing Clinic. Fifteen 
people were eligible to participate, 13 completed the informed consent process, and 12 
completed baseline assessments. Participants completed evaluations related to 
cognitive-linguistic status, nutritional status, physical activity and functioning, and 
cardio-metabolic risk, as well as a past medical history questionnaire and 
questionnaires related to life satisfaction and resilience.  
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Assessment Visit and Data Collection 
Anthropometrics  
Height (cm) and weight (kg) were measured using a stadiometer (Webb City 
Missouri). Height was rounded to the nearest 0.5 cm and weight was rounded to the 
closest 0.1 kg.  Height and weight were used to calculate BMI (kg of body 
weight/height in meters2).  Predetermined categories classified BMI scores: 
underweight <18.5 kg/m2, normal weight = 18.5-24.9 kg/m2, overweight = 25-29.9 
kg/m2 and obese ≥ 30 kg/m2 22.  A foot-to-foot bioelectrical impedance analysis device 
(Tanita BF-556, Arlington Heights Illinois) was used to obtain body composition and 
report percent (%) body fat. American Council on Exercise23, any female with ≥32% 
body fat and any male with ≥25% body fat was considered obese. 
Biochemical  
Following a 12 hour fast, serum total cholesterol, low-density lipoprotein 
cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triacylglycerol, 
and glucose were assayed using the portable Cholestech® (LDX system, Hayward 
California) machine. Total serum cholesterol <200 mg/dL, LDL-C <100 mg/dL, HDL-
C >40 mg/dL, triglycerides <150 mg/dL, glucose <100 mg/dL are considered optimal 
metabolic-lipid profiles24.  
Clinical  
Blood pressure was measured after participants sat quietly for five minutes 
using an automatic blood pressure machine (Omron Healthcare Inc., Bannockburin 
Illinois). Systolic blood pressure (SBP)  <120 mmHg and diastolic blood pressure 
(DBP) <80 mmHg was considered optimal.  Systolic blood pressure >130 mmHg and 
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DBP >85 mmHg was borderline high, while SBP > 140 mmHg and DBP >90 mmHg 
was considered hypertensive.  
Cognitive Linguistic  
Cognitive-linguistic function was assessed using the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS)25. The RBANS includes 12 
subtests, with five index scores, summarizing: immediate memory, 
visuospatial/constructional, language, attention and delayed memory. The total score 
is the sum of the five index scores. Scoring is based on a standardized mean of 100 
and a standard deviation of 15; a score <70 indicates suboptimal cognitive function.   
Swallowing Evaluation 
The Swallowing SWAL-QOL is a 44-item survey where participants rate 
factors about 10 quality of life concepts related to swallowing, primarily in regards to 
eating and diet26,27. The highest possible score is 220, the higher the score the better 
one’s swallowing function. 
Dietary Intake and Nutritional Risk Assessment  
The Dietary Screening Tool (DST) is a 25-item questionnaire that is used to 
identify dietary patterns and nutritional risk in older adults28,29. Participants reported 
how frequently they consumed a food or type of food. A composite score was 
calculated based on subcomponents of the DST. The sub-components and point 
distribution included: whole fruit and juices (15 points), vegetables (15 points), lean 
proteins (10 points), added fats, sugars and sweets (25 points), dairy (10 points) and 
processed meats (10 points), and use of a dietary supplement (5 points). 
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These sum-components are composited and total scores are defined for three 
different nutritional risk levels: (<60) at risk, (60-75) possible risk, and (>75) not at 
risk28.  Categorization into three nutritional risk categories provides a way to 
determine if a patient needs a follow-up or nutrition assessment28. The DST Dietary 
intake was broken down based on point classification for the DST sub-components28 
to explore specific areas contributing to low dietary quality. These sub-components 
were created to identify specific areas of the diet that may be problematic on an 
individual basis28.  
Participants with fewer than 50% of total possible points for each sub-
component and if the participant did not currently take dietary supplement were 
considered low sub-scores. Less than 50% was selected as an exploratory marker to 
indicate infrequent/inadequate intake of whole grains, fruits, vegetables, dairy or lean 
proteins, and high consumption of processed meats, added sugars, fats and sweets. 
Physical Activity and Functioning  
The Physical Activity and Disability Survey (PADS)30,31 was used to assess 
physical activity levels. It covers a wide range of activities and includes six sub-
scores: exercise, leisure-time physical activity (LTPA), general activity, therapy, 
employment, and wheelchair use. The PADS is coded based on intensity, type and 
amount of activity and can detect varying levels of physical activity32. Raw scores of 
<27 indicate minimal, 28-42 is minimal to moderate, 43-67 is moderate, and > 68 
indicates a high activity30.  
The short physical performance battery (SPPB)33 was completed to assess 
participants’ global physical functioning and included usual gait speed, standing 
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balance tests, and five repeated chair stands. SPPB scores are on a 12 point scale, the 
higher the score the better physical function. Scores 8-12 are considered “high 
functioning33.” 
 A timed up and go (TUG) test was used to assess basic functional mobility34.  
It measures the time it takes for the participant to rise from a chair, walk three meters, 
turn around and walk back to the chair. Time was recorded in seconds, and the shorter 
amount of time, the better the score. The test was administered twice and the better 
score was recorded. A TUG score >13.5 is considered high risk for falls35 
Other Questionnaires  
A non-validated medical history questionnaire was be used to identify health-
related conditions and how these conditions may impact health.  
Cardio-Metabolic Assessment  
 Cardiovascular disease is the disease of the heart and/or blood vessels36. 
Traditional risk factors for CVD include modifiable and non-modifiable risk factors. 
Non-modifiable risk factors include age, sex and ethnicity. Modifiable risk factors 
include being overweight/obese, having hypertension, elevated blood glucose levels, 
and dyslipidemia37. As well lifestyle factors such as physical inactivity, tobacco use 
and a diet high in saturated fat and processed foods and low in fruits and vegetables 
and fiber37,38. 
Cardiovascular risk factors were selected based on these risk factors but also 
unique factors that may impact CVD risk for those living with disability. These factors 
were grouped into eight categories, which included: 1) age (>45 years for men, >55 
years for women), 2) anthropometrics (BMI, %BF), 3) clinical (SBP and DBP), 4) 
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biochemical (TC, HDL-C, TC/HDL-C ratio, LDL-C, TRG and Glucose), 5) diet (DST 
scores), 6) physical barriers (use of legs, arm or assistive device), activity (PADS 
scores) and functioning (SPPB and TUG scores), 7) smoking status, and 8) cognition. 
Those living with neurological disorders suffer physical and cognitive impairment that 
may disrupt activities of daily living (ADL); as a result physical barriers (such as 
partial or no use of arms and legs, as well as use of an assistive device) were examined 
due to the possibility they may promote a sedentary lifestyle. Cognitive function was 
also included as a CVD risk factor through examining total RBANS scores and three 
RBANS index scores (immediate memory, attention, delayed memory) <70.   
Statistical Analysis  
Statistical analysis were not hypothesis driven, but conducted to generate 
hypotheses and explore the population. Data were analyzed using SPSS, version 22.0 
for Windows (IBM Corp.  Summers, NY). Descriptive statistics were conducted and 
distribution of data was assessed through analyzing skewness and kurtosis. For data 
that were not normally distributed, proper statistical methods were used to account for 
this. Categorical variables are represented as numbers and percentages and continuous 
variables are reported as mean ± standard deviation. 
To analyze CVD risk factors, the participants were individually analyzed 
across the eight categories.  The most frequent risk factors were then analyzed based 
on the variables within the eight CVD categories and reported as top CVD risk factors.  
 For normally distributed data, independent t-tests were conducted to determine 
if there were significant differences between groups regarding assessment variables. 
Cohen’s d was calculated to describe effect size for differences between groups in 
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normally distributed variables (0.2 = small effect, 0.5 = medium effect, 0.8 = large 
effect). For data not normally distributed, Mann-Whitney U tests were used to analyze 
differences between groups and effect size was signified through calculating r 
(0.1=small effect, 0.3=medium effect, 0.5=large effect).  Differences between groups 
for categorical variables were identified using Fisher Exact Tests. Phi squared or 
Cramer’s V were used to signify effect size (0.1=small effect, 0.3=medium effect, 
0.5=large effect). Pearson’s R correlations were used with normally distributed 
variables, and Spearman Rho correlations were used as the non-parametric alternative.  
Differences between groups were significant when p=<0.05.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
13 
RESULTS 
Demographic characteristics and results from specific assessment measures are 
summarized in Table 1. Of the four ABI participants two were diagnosed with stroke, 
one with a TBI and one participant had a diagnosis of TBI and stroke. An independent 
t-test found, those living with ABI were diagnosed significantly longer than those 
living with PD (p=0.01, d=1.8). All participants self-identified as white/Caucasian and 
of non-Hispanic/Latino ethnicity. Two participants (both with ABI) were employed at 
the time of testing.  The age range was 33 through 71. Comorbidities amongst 
participants included musculoskeletal conditions (osteoporosis, arthritis), cancer, 
cardiovascular (coronary artery disease), previous head injury, and psychological 
disorders (bipolar). None reported endocrine dysfunction, such as thyroid disease or 
diabetes.  
No significant correlation was found between RBANS scores and nutrition, 
cardio-metabolic, or physical assessments. As indicated by DST scores, three 
participants with PD were classified at nutritional risk and seven participants (4 PD 
and 3 ABI) were classified at possible nutrition risk (Table 2). Two participants with 
PD reported diet changes to soft, easy to chew foods, while all other participants 
reported to follow a  “full normal diet,” not modified in texture or consistency. All 
participants reported drinking thin liquids without any modifications.  
Results from 10 DST sub-scores per participant are described in Table 3. When 
examining dietary components, 75% of participants were not consuming enough dairy 
products, and 50% were frequently consuming added fats, sugars and sweets and/or 
not taking a dietary supplement. The majority of participants were consuming fruits, 
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vegetables and whole grains regularly. On average, participants had inadequate sub-
scores in three out of ten DST sub-categories.  
Physical barriers, physical activity level and physical functioning for each 
participated are reported in Table 4. Six participants had partial use of arms and eight 
had partial use of legs, while seven participants reported to use an assistive device. 
The range of PADS scores for participants ranged from -12 to 311. Mean total TUG 
score was 12.1±3.2 seconds. Physical barriers, physical activity level and physical 
functioning for each participated are reported in Table 4.  
The secondary aim of this study was to analyze how compromised cognition, 
nutrition, and physical activity and functioning may increase CVD risk. Seven 
participants were taking medication to manage blood pressure and/or lipid profiles. 
Results of the RBANS revealed that three participants had total index scores <70 (1 
PD, 2 ABI), three participants (1 PD, 2 ABI) had <70 Immediate Memory Scores, 
three ABI participants had <70 Attention scores and two PD and one ABI had <70 
delayed memory scores. In total, five participants had cognitive impairment in one of 
these four areas. Typically, cognitive status is not classified as a CVD risk factor, 
however these tests have been included to explore the potential impact of impaired 
cognition associated with neurological disorders may have on CVD risk. Additionally, 
the presence of possible nutrition risk (Table 3) and compromised physical functioning 
(Table 4) may worsen overtime and evolve into a worse diet and sedentary lifestyle, 
factors that in turn can lead to CVD. The presence of nutrition and cardio-metabolic 
risk factors, including anthropometrics, clinical and biochemical values are reported 
for each participant in Table 2. 
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Participants had three to six risk factors. The most common risk factors are 
highlighted in Figure 1. Body mass index scores ranged from 23.0 kg/m2 to 33.3 
kg/m2.  Additionally, 58.3% participants had elevated SBP and/or DBP, and, 72.7% 
participants had at least one abnormal lipid or glucose level lab value (Table 2).  
An exploratory aim of this study was to examine if there are differences 
between those living with PD and ABI across cognition, nutrition and physical activity 
and functioning. In addition to significantly higher total RBANS scores, those with PD 
scored significantly higher in language (96.9±8.7, 80.00±2.3, p=0.004, d=2.66) and 
attention (95.0±10.4, 56.00±15.9, p=0.000, d=2.90). There was no difference in DST 
or PADS scores between groups.  
A Fisher’s exact test found those with PD were more likely to have full use of 
arms (p=0.061, Phi=0.707) and legs (p=0.208, Phi=0.50), and less likely to use 
assistive devices (p=0.061, Phi=0.598) with a large effect size (Table 4). Overall, 
TUG performance for those with PD was better, 11.1±2.5 seconds versus 14.2±3.8 
seconds (p=0.112, d=0.96), with a large effect size. Participants with ABI had SPPB 
scores below eight. There was also no difference in anthropometrics, clinical or 
biochemical data in those living with PD versus ABI.  
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DISCUSSION 
This baseline study is the first of a 5-year observational study in those with 
neurological disorders to understand the rate and magnitude of change in this 
population, as well to help prevent comorbidities. This study is the first to examine 
cognition, nutrition, and physical activity and functioning together in those living with 
PD or ABI. Findings indicated those living with one of these neurological diagnoses 
present with deficits in cognition nutrition, cardio-metabolic and/or physical 
functioning. Our findings highlight the need for an interdisciplinary team to work with 
this population to help prevent CVD.  The majority of our participants, were 
overweight/obese (n=9) and had DST scores <75 (n=10).  Additionally, 50% 
performed sub-optimally in physical functioning assessments and all presented CVD 
risk factors. 
 A Pearson correlation found a negative correlation between total RBANS 
scores and months elapsed since diagnosis (r=-0.655, p=0.021).  The association 
between RBANS scores and time since diagnosis correlated with previous literature 
regarding cognitive decline in this population39,40. The significantly lower RBANS 
scores for those with ABI may be associated with the significantly longer time since 
diagnosis (5.3±4.3 vs. 14.3±5.6 years, p=0.011).  
While malnutrition with low body weight or eating difficulties may be present 
in these disease states3,5,41,42, none of our participants were underweight and only two 
reported to consume a “soft” modified texture diet.  Ten out of twelve participants had 
<75 DST scores. A score between 60 and 75 indicates possible nutritional risk. Those 
with higher DST scores (a more healthful dietary pattern) have been associated with 
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more favorable biomarkers, health status, nutrient dense diets and body 
compositions28. As a result, we felt it was necessary to examine DST scores <75 
overtime and identify participants with these scores needed improvements in dietary 
quality.  
 The frequent consumption of added fats, sugar and sweets (Table 3) may 
indicate those with cognitive and physical impairment are choosing convenience foods 
frequently. Nine out of twelve participants were not consuming diary frequently, and 
to optimize bone health, future dietary interventions should consider promoting 
consumption of low/reduced fat products high in calcium and vitamin D. As well as, 
encouraging the use of a daily multi-vitamin supplement, if appropriate, and an 
education of which foods provide appropriate amount of calories and nutrients for this 
population.  
Low DST and general activity scores and their relationship suggests further 
investigation of disease-related eating barriers, such as ability to buy and prepare 
meals5,14,43. Altered satiety cues and change in appetite associated with TBI may also 
be present3,42.  It also implies isolated activity time is less of a barrier than performing 
household tasks. Most participants were married or lived with family, and household 
work was performed by someone else.  These findings are consistent with past 
research, which found 86% of those with PD were disabled from participating in ADL, 
but 88.8% had social support, and 64% participated in regular exercise/leisure time 
activity44. Future physical activity interventions should target ways to help increase 
the ability to independently carry out more ADL, which may improve diet quality.   
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Evidence shows physical activity can help reduce age-related physical and 
cognitive decline45-47. The presence of elevated exercise and LTPA activity and their 
correlation with SPPB scores may imply a protective effect of activity on participant’s 
physical decline and should be examined over the next five years.  
Due to the small sample size and the use of pharmacological medications to 
manage blood pressure and/or cholesterol levels by many participants (58.3%), it is 
hard to speculate the risk factor with the biggest impact on the development of a 
cardiovascular event in those with neurological disorders. Despite the use of 
medication to manage lipid profiles and blood pressure, other CVD risk factors were 
still present and may lead to a CVD event. This can be highlighted by presence of 
elevated bodyweight and low dietary scores in many participants and shows the 
importance to continue to monitor and promote heart health in this population.   
Research still needs to better understand the risk of CVD in those with PD and 
whether these is in fact a protective cardio-metabolic effect present in those with PD 
or an increased risk of a CVD event16-18,48,49. Both those with ABI and PD the 
presence of elevated BMI and %BF, suboptimal DST scores and slight abnormality in 
clinical and biochemical values gives reason to continue to monitor those with one of 
these neurological disorders. Especially given the association with TBI and the 
development of cardio-metabolic alterations overtime33,42,50. Due to the small sample 
size of those living with stroke, it is difficult to compare participants and assess if the 
notion of the obesity paradox (those obese/overweight at the time of stroke have better 
functional outcomes12,19) exists a year or more after stroke. 
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While more research is needed to draw conclusion regarding cardiovascular 
risk across these disease states, it is still important to monitor and treat cardiovascular 
risk factors present. Research notes those with multiple marginal risk factors are at 
risk for a CVD event within 10 years51. Those currently taking medication to treat 
hypertension, with suboptimal blood pressure (especially elevated SBP levels) are at 
more increased risk than those not taking medication with elevated blood pressure 
levels51. Four out of twelve of participants were currently taking blood pressure 
medication and presented with elevated/ pre-hypertensive SBP (>130 mmHg).  
Despite the small sample size, the biggest difference between those living with 
ABI or PD were differences in cognitive-linguistic deficits. Cognitive-linguistic 
complications are common across diseases39,52-56, however for PD, older age at disease 
onset, depression, male gender, motor symptom severity, and advanced disease are 
risk factors for cognitive impairment40.  Cognitive symptoms usually appear within 15 
years of PD diagnosis57,58. Only one participant with PD had a low total RBANS 
scores. The two participants with stroke had total RBANS scores >70 while the two 
TBI participants had scores <70. Both TBI participants had low RBANS index scores 
for immediate memory, and attention, which is consistent with the nature of the 
disease39. However, PD progresses, it is likely issues with cognition, nutrition and 
physical activity and functioning may become more pronounced than those living with 
ABI.  
Study Strengths and Limitations 
This is the first study to complete combined assessments of cognition, 
nutrition, and physical activity and functioning in those living with PD or ABI. This 
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interdisciplinary study obtained both subjective and objective data via validated tools 
to assess the study sample and generate hypotheses.  
While this study is novel, it is not without limitations. The small sample size 
and homogeneity of participants does not allow wide generalizability for those living 
with PD or ABI. Participants were predominantly well educated and of 
white/Caucasian decent, and recruited on a voluntary basis. As a result, participants 
likely had an interest and motivation to improve health status. Finally, since there were 
a larger number of PD participants than anticipated, obtaining Hoehn and Yahr 
classifications to identify severity of disability in PD59 would strengthen results. 
Future research should expand recruitment across the three disease states, to 
compare differences between PD, TBI and stroke, rather than just PD and ABI. This 
will allow a better understanding of how cognition, nutrition and physical functioning 
differs across the three diseases.  Research should also expand recruitment to include 
healthy, age-matched controls, to provide insight on how living with neurological 
disorders compare to the healthy population. Once a more complete understanding of 
the population is established, well-defined recommendations and interventions can be 
developed and tested to improve treatment of those with PD and ABI. 
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CONCLUSION 
Suboptimal cognition, dietary quality, physical functioning, and cardio-metabolic 
risk factors are frequently reported in patients with neurological disorders. These 
findings confirmed the presence of cognitive, dietary and physical decline in our 
participant group and support the need for an interdisciplinary team to work with 
patients and caregivers to improve health and prevent further development of 
comorbidities in this population. 
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*Indicates statistically significant differences between PD and ABI groups (p<0.05). Notes: values 
provided for total number of participants and by disease state expressed as mean± standard deviation. 
Differences between groups for all normally distributed variables analyzed using independent t-tests, 
Cohen’s d for effect size (0.2 = small effect, 0.5 = medium effect, 0.8 = large effect).  †Between group 
differences conducted using Mann-Whitney U Test, effect size reported as r (0.1 = small effect, 0.3 = 
medium effect, 0.5= large effect). ‡Between group differences for categorical variables provided using 
fisher exact test, effect size for fisher exact test using phi coefficient or Cramer’s V (0.10 = small, 0.30 
= medium, large = 0.50).  Abbreviations: Dx, diagnosis 
TABLES AND FIGURES 
 
 
  Table 1: Characteristics of All Participants and by Neurological Disorder 
 All (n=12) PD (n=8) ABI (n=4) Effect Size 
Age (years)† 60.0±12.4 65.5±5.0 49.0±16.1 0.54 
Months Since Dx. 99.3±75.5 63.4±51.3 171.0±66.7
* 1.91 
Gender%(n)‡    0.250 
Men 66.7(8) 75.0(6) 50.0(2)  
Women 33.3(4) 25.0(2) 50.0(2)  
Education Level %(n)‡    0.463 
HS Diploma  25(3) 12.5(1) 50.0(2)  
Bachelors 16.6(2) 25.0(2) 0(0)  
>Graduate Degree  58.3(7) 62.5(5) 50.0(2)  
RBANS Total  80.1±17.0 87.1±14.6 66.0±12.6* 2.455 
Height (cm) 170.1±9.2 170.5±6.98 169.4±14.1 0.10 
Weight (kg) 78.4±15.0 79.7±14.1 75.7±18.7 0.25 
BMI (kg/m2) 26.8±3.0 27.3±3.3 26.0±2.4 0.40 
BMI Categories%(n)‡    0.217 
Normal 25.0(3) 25.0(2) 25.0(1)  
Overweight 66.7(8) 62.5(5) 75.0(3)  
Obese 8.3(1) 12.5(1) 0(0)  
Body Fat (%)  30.0±6.5 29.9±6.7 30.1±7.2 0.02 
TC (mg/dL)† 182.9±37.3 (11) 169.1±28.9 (7) 207.0±42.0 (4) 0.139 
TAG (mg/dL)†  131.00±70.0 (11) 132.7±73.8 (7) 128.0±73.6 (4) 0.286 
HDL-C (mg/dL)† 48.6±20.4(10) 43.7±12.7(7) 60.0±33.5(3) 0.109 
LDL-C (mg/dL)†  99.6±30.6(10) 98.9±27.6(7) 101.3±43.8(3) 0.03 
Glucose (mg/dL)† 87.0±12.9(10) 91.2±7.9(6) 80.8±14.5(4) 0.2365 
SBP (mmHg)† 133.7±17.0 138.6±18.5 124.0±8.8 0.343 
DBP (mmHg)† 79.0±9.0 80.3±9.9 76.5±7.2 0.196 
DST 64.3±12.4 61.1±13.6 70.8±7.0 1.308 
SWAL-QOL 188.0±20.6 176.9±15.0 210.3±6.1* 4.188 
PADS†  94.9±89.7 89.7±99.6 108.7±71.5 0.143 
SPPB 8.7±1.6 9.3±1.0 7.5±2.1 1.996 
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 Table 2: Nutrition & Cardio-Metabolic Risk Factors By Participants  
 
 
Diagnosis 
Months 
Since 
Diagnosis 
BMI 
(>25 
kg/m2) 
%BF* 
 
 
DST 
<75 
SBP 
>130 
mmHG 
DBP 
>85 
mmHG 
TC 
>200 
mg/dL 
HDL-
C, 
<40 
mg/dL 
TC/HDLC 
>5:1 
LDL-
C 
>100 
mg/dL 
TRG 
>150 
mg/dL 
Glucose 
>100 
mg/dL 
Smoking 
Status 
Total 
# of 
RF/PPT 
PPT1† ABI 216 X X X X         4 
PPT2  PD 96   X        X  2 
PPT3† PD 12 X X X  X  X  X    6 
PPT4 ABI 240 X  X  X X   X    5 
PPT5 ABI 120 X N/A     X X X X   5 
PPT6 ABI 108   X   X N/A N/A N/A    2 
PPT8‡§ PD 36 X X  X X        4 
PPT9 PD 36 X  X X         3 
PPT10† PD 36 X X X X X N/A N/A N/A N/A N/A N/A  5 
PPT11† PD 113 X X X    X X X X  X 8 
PPT12† PD 23  X X       X N/A X 4 
PPT13‡ PD 155 X X X X  X X X X X   9 
TOTAL RF 9 7 10 5 4 3 4 3 5 4 1   
*Based on guidelines from American Council of Exercise, females with ≥32%BF and males with ≥25%BF; †PPT currently takes blood pressure medication;  
‡PPT currently takes blood pressure & lipid lowering medication; §PPT had history of coronary artery disease. Abbreviations: BMI, Body Mass Index;  
%BF, percent body fat; BP, blood pressure, TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol;  
TRG, triglycerides; PADS, physical activity and disability scale; DST, dietary screening tool; RF, Risk Factors 
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Note: Check marks indicate fruit & juice, vegetables, whole grains scores <7 out of 15 points, lean protein, dairy, 
processed meats scores <5 out of 10, added fats, sugar, sweets <12 out of 25, and if the participant did not take a 
supplement. PPT 5 and 8 were not at nutritional risk. Abbreviations: PPT, participants; DST, dietary screening tool 
 
 
 
 
 
 
 
 
 
 
 
Table 3: DST Sub-Scores by Participant  
PPT Diagnosis 
Fruit 
&Juice 
 
Vegetables 
Whole 
Grains 
 
Lean 
Proteins 
 
Added 
Fats, 
Sugar, 
Sweets 
Dairy 
 
Processed 
Meats 
 
Supplement 
 
Total Sub-
Categories 
PPT1 ABI   X X    X 3 
PPT2  PD     X X  X 3 
PPT3 PD    X X X  X 4 
PPT4 ABI     X X X  3 
PPT5 ABI          
PPT6 ABI X   X  X   3 
PPT8 PD      X   1 
PPT9 PD  X  X  X   3 
PPT10 PD     X X  X 3 
PPT11 PD      X  X 2 
PPT12 PD  X X  X    3 
PPT13 PD X X X  X X X X 7 
Total:  2 3 3 4 6 9 2 6  
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Table 4: Physical Barriers, Physical Activity and Physical Function  
 
  PHYSICAL BARRIERS  ACTIVITY LEVELS 
PHYSICAL FUNCTION 
MEASURES 
 
PPT 
Diagnosi
s 
Arms Legs 
Assistive 
Device 
Fall 
Frequency 
PADS 
<42 
Exercise† 
 
LTPA† 
General 
Activity† 
SPPB 
<8 
Balance 
<2 
TUG 
≥ 
13.5 
sec 
 
Total RF 
PPT1 ABI X X X    X   X  5 
PPT2  PD  X X X   X X  X  6 
PPT3 PD  X X        X 3 
PPT4 ABI X X X  X X X X X X X 10 
PPT5 ABI X X X      X  X 5 
PPT6 ABI X X X     X    4 
PPT8 PD            0 
PPT9 PD        X    1 
PPT10 PD X X      X    3 
PPT11 PD X X X X X X X    X 8 
PPT12 PD    X X X X X    5 
PPT13 PD        X    1 
Total RF 6 8 7 3 3 3 5 7 2 3 4  
Check marks indicate participants are at risk of poor physical function and activity level. Portray poor physical function and activity level. Physical barriers include if 
participant has partial use of arms or legs, uses an assistive device, and reports frequent falls. †Indicates PPT does not participate in PADS sub-scores (exercise, 
leisure time, or general activity) and received a score of 0 or below. Abbreviations: PPT, participant; LTPA, Leisure-Time Physical Activity; RF, risk factor 
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Figure 1: Most Common Nutrition, Cardio-Metabolic and Physical Risk Factors 
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APPENDIX A: Review of Literature  
  
I. Introduction  
 
Parkinson’s disease (PD), traumatic brain injury (TBI), and stroke are neurological 
conditions that can result in lifelong challenges that affect physical, cognitive and 
psychosocial functioning1-5, which in turn can jeopardize dietary intake and increase 
likelihood of nutritional and cardiovascular disease (CVD) risk. Traumatic brain injury 
and stroke are subtypes of acquired brain injury (ABI), a term used to describe 
structural damage to the brain6,7. Approximately 1,700,000 and 795,000 people 
experience a TBI or stroke, respectively, every year in the United States (US)7,8. 
Parkinson’s disease is a progressive, neurodegenerative, movement disorder that one 
million people in the US live with9. While these neurological diseases are each unique 
and have different long-term impacts, they have similar complications that can 
negatively impact nutritional status and dietary intake1,3,10. 
Limited research exists examining the relationship between cognition, nutrition 
and physical activity in those with one of these neurological disorders.  Research has 
examined long-term (a year or more following diagnosis) nutritional status of those 
living with PD 1,11,12. Unintentional weight loss is typical at the time of PD diagnosis 
and nutritional status declines as the disease progresses1. Meanwhile, nutritional status 
of patients in the acute stages of stroke and TBI has been assessed and malnutrition 
and muscle wasting are consistently reported13-16. Evidence indicates up to six months 
following a stroke and two months following a TBI are a high-risk time for 
malnutrition5,17, however very little research has examined nutritional status a year 
after.  Since nutritional status is compromised in the acute phase after an ABI, long-
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term nutritional status is likely to be poor16. In addition to risk of poor nutritional 
status, physical disabilities associated with these neurological disorders3,18,19,20 warrant 
an assessment of physical activity and functioning. An assessment of both nutrition 
and physical activity will provide a clearer idea of if these neurological disorders are 
at increased risk of diet and exercise related comorbidities.  
Research indicates there may be a protective cardio-metabolic effect of PD, 
even in those with PD that are overweight21,22. Meanwhile, those with TBI are at 
increased risk for significant weight change, as well diseases related to physical 
activity and diet, such as coronary heart disease (CHD) and metabolic syndrome, a 
disease marked by abdominal obesity, hypertension, dyslipidemia and insulin 
resistance3,23. Research indicates an obesity paradox seems to exist following stroke, 
decreasing risk of reoccurring stroke15,24, however a cardiovascular risk assessment of 
those living with stroke has not been completed.  
Due to complications of neurological disorders, it is implied that nutritional 
imbalances can result in over-nutrition or under-nutrition1,3,5,17,23. While research has 
examined nutritional status in those with PD, limited research exists analyzing how 
cognition, nutrition and physical activity and functioning relate. Similar complications 
of these three disease states suggest research should examine long-term nutritional 
status of those with stroke and TBI, as well as cognition and physical activity. Due to 
this lack of research, a cross-sectional study including those living with PD, TBI and 
stroke is necessary to assess dietary quality, nutritional status, physical activity and 
physical functioning, as well as cardiovascular risk, and quality of life.  
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II. Parkinson’s Disease   
The Definition, Prevalence and Effects of PD 
Parkinson’s Disease is a neurodegenerative, movement disorder caused by the 
death of dopamine cells9. Dopamine cells are the neurons that regulate motor 
function25 and are concentrated in the substantia nigra, the area of the brain that 
controls movement26.  In addition to motor symptoms (partial or full functional loss of 
a body part), those living with PD experience a variety of cognitive deficits, even 
during early stages of the disease27.  The direct and indirect cost of total PD in the US 
is approximately $25 billion per year9. Up to 60,000 new cases of PD occur annually 
in the US28 and once motor symptoms are apparent up to 80% of the dopamine-
producing cells are dead26. These motor and non-motor symptoms develop overtime 
and impact daily activity1 and negatively impact quality of life27.  
Parkinson’s disease is one of the most common late-life (beginning in the sixth 
or seventh decade of life) neurodegenerative diseases, impacting up to 2.0% of people 
60 years and older29. Men are one and a half times more likely to be diagnosed with 
PD than women9. Common motor impairments include bradykinesia (slowness of 
movement), akinesia (difficulty initiating movement), tremors, and rigidity30. The 
three commonly identified subtypes of PD are based on major motor symptoms: 1) 
tremor dominant, 2) postural instability gait disorder and 3) akinetic-rigid31,32. Postural 
symptoms are more common in women, while symmetrical upper-disease related 
motor symptoms are more common in men33.  
Parkinson’s can be classified into a variety of different subtypes, usually based 
upon the dominant motor symptoms present.  Parkinson’s can also be identified in 
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stages based on the Hoehn and Yahr scale (HY)34. This one through five scale was 
developed to describe degree of disability and functional limitations related to PD34. 
Phase one describes early onset symptoms, while stage five would describe the final 
phases, where one is confined to a wheelchair or bed.  The progression of the disease 
is usually marked by increased motor impairment9. These motor symptoms, as well as, 
non-motor symptoms, can impact dietary intake and compromise nutritional status35,36. 
Non-motor symptoms prevalent in PD include: cognitive impairment, neuropsychiatric 
symptoms, sleep disturbances, fatigue, gastrointestinal symptoms and sensory 
disturbances37,38. Cognitive dysfunction can occur early in diagnosis39.  
Parkinson’s Disease and Effects on Cognition   
 Parkinson’s disease is associated with a variety of cognitive deficits that appear 
in the earliest stages of the disease and continue to worsen as the disease 
progresses27,37,38. Within 15 years of diagnosis, over 80% of those living with PD 
experience a form of cognitive impairment (deficiency in brain function that affects 
memory, language, perception, visuospatial aspects, ability to carry out tasks and 
judgment)40 or dementia41. These alterations can interfere with everyday functioning27. 
Older age at disease onset, depression, male gender, severity of motor symptoms and 
advanced disease stage are risk factors for the development of mild cognitive 
impairment (MCI) for those with PD10. Evidence of MCI in the early stages of PD is 
associated with the incidence of dementia in later stages of PD42.  
Cognitive symptoms associated with PD are mostly a result of the pathological 
changes within the brain, including changes in the dopaminergic pathway43. 
Dopaminergic drugs, such s levodopa (L-dopa), used to synthetically produce 
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dopamine have been associated with improving cognition in PD patients, as well as 
negatively impacting cognition44,45. There are multiple reasons for cognitive changes 
in those with PD and many pathways are disrupted as a result of lack of dopamine 
deficiency.  In addition to lack of dopamine, the presence of Lewy body production 
(abnormal aggregates of protein that develop inside nerve cells and interfere with 
signal conduction) and cell loss in the brain can also disrupt cognitive function39,46.  
In those newly diagnosed with PD, the most prominent cognitive issues are 
related to memory and executive functions (EF)47. Executive function is the set of 
mental processes that help one connect past experience with present action48. Deficits 
with EF include difficulty with concept formation, decision-making, cognitive 
flexibility and selective attention37,47,49.  Difficulties with EF can be attributed to 
damage of the frontal cortex as a result of PD47,49. A cross-sectional study examining 
the pattern of EF in 34 participants with mild to moderate PD, with a mean duration of 
68.2±52.4 months, found nearly 45% of participants had a degree of EF impairment49.   
Those living with PD have issues with dual-tasking, which are tasks that 
require simultaneous performance of at least two cognitive functions along with motor 
functions43. Wild and colleagues27 examined dual tasking, in those with PD (n=18) 
versus healthy older adults (n = 18) and found that those with PD compromised the 
cognitive function tasks to focus on the motor task27. Poor dual tasking is also an 
indicator of impaired EF. These symptoms may contribute to a compromised quality 
of life and health status39,47, which in turn may impact one’s ability to make proper 
dietary choices. 
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In addition to compromised EF and memory, neuropsychiatric conditions, 
including depression, anxiety and apathy, often precede motor symptoms50. These 
conditions add significant burden to PD43 and impact quality of life51. Paranoid 
delusions, hallucinations, impulse control disorder, and addictive symptoms can result 
due to treatment and medications for PD43. These cognitive and neuropsychiatric 
impairments, combined with motor impairment, not only impact quality of life but 
have physiological side effects on the body that impact energy needs1. 
Physiological Side Effects and Energy Needs of PD  
 
Physiological side effects and energy needs vary depending on the stage of the 
disease1,52 Unintentional weight loss preceding a PD diagnosis is common53, and 
weight then tends to increase immediately after diagnosis when treatment is 
initiated1,52. The initial pre-diagnosis weight loss is attributed to the energy imbalance 
from the increase in energy expenditure as a result of motor symptoms, such as 
rigidity and dyskinesias (involuntary muscle movements) compared to reduced energy 
intake.  A longitudinal, prospective study examined weight changes of 468 people 
with PD and found a mean weight loss of 5.2 pounds 10 years preceding diagnosis, 
but a fairly constant weight two to four years prior to diagnosis53. Physiological 
changes in PD can also impact desire to eat as a result of hyposmia (reduced ability to 
smell) and change in eating habits as a result of PD1,54. Generally, nutritional status 
declines as the disease progresses and resistance to various forms of available 
treatment develops (Figure A)1. However, findings have contradicted this decline in 
weight as a result of treatment52. 
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Figure A:         1
 
                        
Malnutrition and PD: Under-nutrition 
Malnutrition, or poor nutritional status, is defined as an imbalance of energy, 
macronutrients and/or micronutrients that results in compromised body shape, size and 
composition, function and clinical outcomes55. It includes under-nutrition, which 
results from insufficient intake to meet energy expenditure56, and over-nutrition, 
which is caused by excessive calorie intake and/or inadequate activity56.  Protein-
energy malnutrition refers specifically to deficiency rather than an excess of protein 
and energy36. It also can result in a lower quality of life and poorer health outcomes, 
which in turn can increase risk of falls, hospitalization and admittance to aged care 
facilities36,57,58. Assessments of nutritional status determine if one is malnourished 
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through examining anthropometrics, biochemical and clinical data, and dietary intake.  
Nutrition assessments of those living with PD typically find compromised nutritional 
status11,12,59. 
The average age of those diagnosed with PD is 60 years old60. Change in 
weight, particularly weight loss, during aging is typical61, yet it seems to be greater in 
those with PD62.  Changed in total body weight in men and woman overtime varies. 
Typically, men gain weight until about the age of 55 and women until the age of 65; 
after this point in time weight loss is common.  Weight loss in healthy aging adults 
occurs because of the loss of lean muscle tissue, which is replaced with fat61.  
Under-nutrition is prevalent in those living with PD11,12,59, however it is 
difficult to determine how much of it is due to PD36. The majority of PD patients are 
elderly and as a result are also experiencing physiological changes associated with 
aging61. In addition to weight loss, changes include reduction of digestive secretions, 
intestinal absorption, protein synthesis, and factors that decrease energy intake63; these 
factors include altered sense of smell and taste, loss of teeth and ill-fitting dental 
prostheses63. A mean weight loss of 7.7 pounds during the 8 years following diagnosis 
of PD has been reported53. The study found energy intake to be similar between those 
with PD and those without PD shortly before diagnosis, but saw an increase in energy 
intake shortly after the diagnosis of PD53.  This research implies that weight loss 
associated with PD can be due to an increase in energy expenditure unique to PD, that 
healthy adults to do not experience53.  
Compared to age matched controls, research has found lower body mass index 
(BMI) scores in those with PD64. Other study have also found those with PD to have 
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significantly lower BMI scores (24.4±0.5 kg/m2) and percent body fat (%BF) 
(22.2%±0.9) compared to age-matched controls without PD (26.3±0.4 kg/m2, 
24.6%±0.9)62. The majority of these participants were in stage two of PD34,62.  
Motor and non-motor symptoms1,36 often compromise dietary intake in those 
living with PD36,59 and may also impact malnutrition. As PD progresses, a decreased 
response to treatment occurs and motor control declines1,65. Decline in motor control, 
such as the presence of dyskinesia and rigidity raises energy expenditure and can lead 
to negative energy balance and weight loss1. Physical changes and motor symptoms 
such as curve posture, shuffling gait and postural instability1 make buying, preparing 
and eating food independently difficult1,35,66.  This development of chronic disabilities 
can interfere with activities of daily living (ADL), which include washing, dressing, 
eating and walking58. Those with PD lose the ability to eat independently due to 
decreased hand-mouth coordination and decline in fine movements to use utensils30,67. 
Motor symptoms can lead to a reduction in energy intake and weight1,66. 
Non-motor symptoms can also cause a decline in dietary intake36 and includes 
depression, dementia, confusion, and apathy, as well as gastrointestinal symptoms; 
typical gastrointestinal symptoms include  constipation, dysphagia (difficulty 
swallowing), early satiety, decreased gastric transit time, nausea, change in taste, loss 
of appetite and sialorrhea (excessive drooling), also cause a decline in dietary 
intake1,36,68,69. A qualitative study examined food shopping, cooking and eating habits 
in older women with PD, and found decrease in sense of smell, appetite and taste in 
combination with issues transporting food to the mouth and swallowing were major 
issues associated with altering nutritional status70. Due to these barriers to meet 
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nutrient and energy needs, those with PD are at increased for weight loss and loss of 
lean body mass36. Weight loss is a natural part of the aging process, yet seems to be 
more common and severe in those with PD62.  
Research indicates lower body weight and barriers for inadequate dietary 
intake in this population, indicating under-nutrition is present in this population. 
Findings reveal a strong correlation between lower Mini Nutritional Assessment 
(MNA) scores and time since PD diagnosis65. A cross-sectional, population-based 
study, which included 135 PD cases in two regions of North East England, found that 
21 of the 135 (15.4%) participants were classified as malnourished11. The study also 
found that females with PD, were more likely to be severely malnourished (BMI 
<18.5) than male counterparts11; this research is consistent to males and females 
without PD71.   
Sheard and colleagues72 found similar results, where 19 of 125 (13%) 
participants were considered moderately malnourished, and, females were more 
frequently malnourished and more likely to experience unintentional weight loss 
compared to males with PD.  Malnourished males in this study had a significantly 
higher median BMI score (21.1 (range:19.5-33.2) kg/m2) compared to malnourished 
females (19.5 (range: 17.7-21.6) kg/m2)12. Males also had a significantly higher 
median waist circumference (86.75 (ranger: 78.9-116.0) cm) compared to females 
(73.5 (Range: 65.5-88.0) cm)12. Patient-Generated Subjective Global Assessments in 
this study suggest muscle wasting in malnourished men and women living with PD12. 
Due to the larger BMI scores and waist circumference in malnourished men with PD, 
accompanied by the presence of muscle wasting, these malnourished participants are 
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likely suffer from sarcopenic obesity, while malnourished females may suffer from 
both muscle and fat loss12. Sarcopenia is the age-related loss of lean muscle mass and 
muscle function73-75. These results indicate that nutritional assessments for those living 
with PD are necessary. More research is needed to understand exactly why 
malnutrition occurs in this population and to help prevent malnutrition and sarcopenia, 
as well as to monitor how medications and treatment impact weight in this population. 
Medications and treatment for PD may also impact weight and food 
choices1,64,76. Dopaminergic treatment has been associated with a decrease in weight 
for those with PD who experience dyskinesia, common complication of L-dopa64.  
Lower BMI scores are associated with advanced PD patients taking higher dosages of 
L-dopa64. A common side effect of L-dopa is nausea and vomiting, to help limit this 
prescribed with carbidopa as to reduce symptoms of nausea and vomiting and help 
control PD symptoms. Reducing symptoms of nausea and vomiting, as well as seeking 
alternative treatments may help those with PD reduce risk of weight loss While under-
nutrition and weight loss are problematic for those with PD, weight gain can also 
occur and is associated with PD treatment1. 
Malnutrition and PD:  Over-nutrition  
Time of PD diagnosis is often associated with weight gain, because those 
living with PD begin treatment to control symptoms that promote weight loss1. While 
some research has found weight loss in response to treatment for PD, other research 
has reported weight gain as a result. For instance, surgical procedures to treat PD, such 
as deep brain stimulation (DBS) are associated with significant weight gain52,77.  
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 Pharmacological medications can also cause weight gain52,76.  Dopamine 
agonists are medications that stimulate the parts of brain to believe it is receiving 
dopamine. Since they are not as potent as L-dopa, they are less likely to cause 
dyskinesia78, which in turn would decrease energy expenditure associated with 
dyskinesia.  They also can cause compulsive behaviors, include compulsive eating and 
undesirable weight gain76. In a report by Nirenberg and Waters76, seven cases of PD 
are described that experienced compulsive eating and undesired weight gain related to 
dopamine agonists, these participants saw an average 15% increase (13 kg ± 7 kg)  in 
body weight. Five of the seven participants decreased or discontinued dopamine 
agonists and self-reported a decrease in food cravings and weight76. Despite a small 
sample size findings suggest further research should evaluate the impact of dopamine 
agonists, weight status and dietary habits on those living with PD.  
Another treatment that impacts weight is DBS, a surgical option for those with 
PD, and utilized by approximately 30,000 people with PD worldwide79. In this 
surgical procedure, an impulse generator is placed under the collarbone that provides 
an electrical impulse to the substantia nigra79. It typically is recommended for those 
with PD who have complications from medication such as dyskinesia and severe 
motor fluctuations, as well as those who no longer responding to pharmacological 
treatment30. The procedure can effectively reduce motor symptoms, which allows for a 
decrease in pharmacological medications80. The effectiveness can reduce L-dopa 
dosage, in turn reducing negative side effects that impact dietary intake, such as 
nausea, vomiting, and involuntary movements associated with the medication.  
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Deep brain stimulation is also associated with an increase in appetite and 
restoration of hormonal balance. As a result, DBS promotes significant weight 
gain52,76,81. An investigation of weight gain in 30 PD patients receiving DBS found 29 
participants (96.7%) experienced weight gain within one year of treatment52; the mean 
weight gain was 9.3± 6.2 kg52. Just over 46% reported increased weight within the 
first three months52.  Additionally, 24% of participants reported weighing the most in 
their lifetime52. None of the participants experienced weight loss and there was a clear 
shift from being underweight and normal body weight to being overweight and 
obese52.  
Contradicting previous research, a higher prevalence of overweight and obesity 
in those with PD seems to exist compared to the general population63. Of 134 
participants, 62% of participants were classified as obese or overweight, while 3% 
were classified as underweight63. The mean duration of PD was 10.6±5.3 years and 
mean age of participants was 65.9±8.9 years63. In comparing these participants to the 
general population, there was a higher proportion of obese people living with PD than 
living without PD (25 vs. 14%)63. However there seems to be an inverse relationship 
between the course of PD and BMI63. This highlights that while under-nutrition and 
excessive weight loss are an issue for those living with PD, weight gain and obesity 
are also present. Excessive weight gain and obesity are risk factors for CVD and other 
chronic diseases82  
Both weight loss and weight gain has been observed in this population and it is 
understood that nutritional status in those with PD is likely compromised36 and to 
worsen as the disease progresses1.  Consequently, a nutrition assessment, evaluation, 
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monitoring and possible treatments should be included in the treatment plan for those 
with PD1.  Additionally, neurological disorders, such as TBI and stroke, with similar 
cognitive and physical complications as PD, may also experience malnutrition.   
III. Traumatic Brain Injury  
 
The Definition, Prevalence and the Effects of TBI.  
 Traumatic brain injury occurs from an external mechanical force, such as a jolt 
or blow to the brain, that causes brain dysfunction83. There are two types of severe 
TBI’s, closed and penetrating84. A closed TBI is caused by movement of the brain 
within the skull and can be caused by falls, motor vehicle accidents, or being struck 
with an object84. Penetrating head injuries are caused when a foreign object enters the 
skull and includes being struck with a sharp object or a firearm injury84.  
 Each year, approximately 1.7 million people in the US endure a TBI and about 
275,000 are hospitalized8. In the US, the total annual economic cost of TBI is $60 
billion85. Those sustaining a TBI is bimodal, occurring primarily in younger or older 
adults86.  Older adults have the highest rates of TBI hospitalizations and deaths8,87. The 
leading cause of TBI is falls (35%), followed by motor vehicle-related injuries (17%) 
and a strike or blow to the head (workplace or sports-related injuries) (16.5%)8.  
However, approximately 21% of the causes are unknown8.  Amongst, military 
personnel, one in six U.S. service members deployed in support of Operation Enduring 
Freedom (OEF) or Operation Iraqi Freedom (OIF), sustained a TBI88.  
Complications following TBI persist as time progresses89. Up to 5.3 million 
people (1.7%) in the US live with long-term disabilities as a result of a TBI85, making 
TBI the leading cause of disabilities. Long-term disability is defined as the loss of one 
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or more physical or mental functions85. A model created to predict long-term disability 
following TBI hospitalization found about 43.3% of a population based sample 
sustained long-term disability90; findings highlight side-effects of TBI are a serious 
public health issue in the US90.  
Following TBI, chronic, late emerging health implications can occur and 
include neurologic, mobility, endocrine, swallowing and gastrointestinal issues3. 
Breed and colleagues86 examined those who sustained a TBI up to four years ago, and 
noted that younger and older adults with TBI reported musculoskeletal issues more 
frequently than those living without TBI. In addition to physical impairment, acquired 
cognitive impairments as a result of TBI can impede everyday activities and interfere 
with productivity, independence as well as safety91. As a result, it is essential to 
manage the effects of TBI and analyze how cognition, nutritional status and physical 
function are impacted a year or more after injury. 
 TBI and Effects on Cognition   
 
 The cognitive effects following a TBI can last a life-time86. Neurological 
difficulties following TBI include seizures, spasticity, balance difficulties, loss of 
urinary control, communicative impairment, and chronic headaches89.  Individuals 
who sustain brain injuries frequently have trouble with concentration, memory, 
perception, attention, social interaction, managing emotions, problem solving, and 
decision making91. These complications can interfere with multiple aspects of all 
aspects of daily activity91.  A study analyzing functional status among OEF/OIF 
veterans with a history of TBI found reduced functional status was strongly correlated 
with poorer cognitive function92,  particularly related to motor function, processing 
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speed and executive function92. These impairments highlight TBI’s impacts cognitive 
functions related to carrying out ADL and to make decisions.  
Cognitive complications in those living with TBI change over time. However, 
research indicates after a mild to severe TBI, cognition improvement occurs during the 
first two years, but remains impaired beyond this point93. During the early recovery 
phases, people seem to have problems with arousal, attention and memory91.  
Although problems with attention and memory persist overtime, particular difficulties 
with executive function, attention and cognitive control mechanisms become more 
prominent91.  A longitudinal study followed older adults with TBI for 12 months 
following injury, finding poor processing speed, verbal, memory, language and 
executive function compared to older adults without TBI94. Traumatic brain injury is 
also associated with increase risk for PD and other neurodegenerative diseases95,96. 
Furthermore, older adults with closed TBI tend to have issues with naming and 
word fluency under timed conditions, as well as with verbal and visual memory97.  
Impaired cognitive function in this population seems to exacerbate other health related 
issues3 and the Brain Injury Association of American recognizes additional research is 
necessary to further understand the disease and develop clinical guidelines and 
modifications91. Additionally, how these cognitive issues impact dietary intake, 
nutritional status and whether they promote nutritional risk needs to be further 
examined. 
Physiological Side Effects and Energy Needs of TBI 
Research has extensively examined the physiological side effects and impact 
on nutritional status during the acute phase of TBI, from time of diagnosis to six 
  
  
 
49 
months10,11.  The body undergoes hyper-metabolic, hyper-catabolic, and hyper-
dynamic responses13. These physiological responses are not only a result of the injury, 
but due to unfavorable secondary events from TBI98. These secondary events include 
fever, increased intracranial pressure, and seizures98  Consequently, following a TBI 
the body’s energy expenditure and nitrogen excretion increase14.  This increased 
energy expenditure results in a catabolic state, increasing muscle breakdown as well as 
negative effects on immune function and morbidity99.  Energy and protein needs 
increase and meeting these requirements is imperative to prevent and prolong muscle 
wasting and excessive weight loss13. To treat those with a TBI during the acute phase, 
early nutrition support decreases risk for morbidity and mortality100,101.  
A retrospective study explored nutritional treatment (parenteral and enteral 
nutrition) and outcomes up to six months after a TBI13. A nutrition assessment found 
68% participants exhibited signs of malnutrition during this time period, with up to 
29% body weight loss13.  This study revealed that in most participants weight 
continued to decrease one to two months after injury13, highlighting the increase in 
energy expenditure and importance of adequate nutrition during the immediate stages. 
However, what happens beyond this point in those living with a TBI needs to be 
further examined.  
Malnutrition and TBI: Under-nutrition  
Nutritional status following the acute phase of a TBI has not been extensively 
examined. Research has been reported immediately following a TBI and found those 
living with TBI seem to reach lowest weight two months after injury13. Research has 
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also examined nutritional status up to six months after injury, typically this time is the 
rehabilitation stage13.  
While research has not examined nutritional status in those living with TBI a 
year or more, chronic complications following a TBI may compromise dietary intake 
and lead to poor nutritional status3.   Self-reported chronic issues of TBI include 
changes in weight and appetite, sensory changes, swallowing problems, chronic pain 
and dystonia (a neurological movement disorder)3. Due to similar chronic symptoms 
in those living with PD and TBI, there is reason to assesses the impact physical and 
cognitive disabilities, including depression associated with TBI3, has on nutritional 
status and ability to buy and prepare food. This is especially true since research has 
shown physical and cognitive disabilities impact dietary intake and promote difficulty 
preparing meals in those living with PD1,36,68,69,70. 
In a systematic review, Murphy and Carmine3 note dysphagia is common 
immediately following a TBI, and can persist or even worsen overtime. Achieving 
adequate nutrition and hydration can be a lifelong challenge for those living with TBI 
and dysphagia3. Compared to the general population, those with TBI are two and a 
half times more likely to die of digestive disorders102. The most common digestive 
disorders include gastro-esophageal reflux disease, which occurs when acid re-enters 
the esophagus due to irregular relaxation of the lower esophageal sphincter. It can 
cause heartburn, regurgitation, dysphagia, aspiration pneumonia, chest pain and 
nausea3. While, gastrointestinal disorders can cause a decrease in dietary intake and 
weight loss, it is often caused by obesity, use of steroid medication and hiatal hernia3.  
 
  
  
 
51 
Malnutrition & TBI: Over-nutrition  
A common late-onset complication of TBI is weight gain3. Excessive weight 
gain associated with TBI can be due TBI’s impact on metabolism and hormone 
production, memory, self-regulation, mobility, altered satiety cues, and appetite 
altering medications3,86. Weight gain for those with disabilities significantly increases 
risk for CVD, diabetes, functional dependence, and immobility3. Weight gain in TBI is 
associated with metabolic syndrome, which can lead to stroke, retinopathy, peripheral 
artery disease, diabetes and cardiovascular disease3,86. 
Additionally, TBI is associated with post-traumatic hypopituitarism (PTHP) 
(decrease in the release of pituitary hormones to regulate homeostasis in the body); 
approximately 25% of long-term survivors have post-traumatic hypopituitarism103.  
The number of people with PTHP after a TBI is a concerned because the condition is 
associated with increase in weight and metabolic imbalances up to two months after a 
TBI104. The pituitary gland is a vital link between the nervous system and endocrine 
system and releases hormones that impact metabolism and other life processes105. It is 
often undiagnosed in those with TBI because of the underlying primary diagnosis of 
TBI, but can be treated with hormone replacement therapy103. Klose and colleagues23 
found those with TBI and PTHP have higher body compositions and BMI compared 
to those without PTHP up to 12 months after injury. An increase in BMI from three 
months (27.1 ± 5.7 kg/m2) after injury to 12 months (29.3± 5.7 kg/m2) was found23. 
Those with PTHP were also older, and had a more severe TBI. What happens beyond 
this point regarding weight and body composition needs to be examined.  
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Weight change is a common theme in those living with TBI23.  Hibbard and 
colleagues89 found those living with TBI for a year or more reported unintentional 
weight loss or gain greater than ten pounds.  However, to our knowledge, the research 
has not examined long-term (12 or more months following TBI) weight status and 
dietary intake in people with TBI. How diet, as well as physical inactivity, plays a role 
in weight gain and if weight gain continues overtime needs to be examined. Since 
research indicates nutritional status and weight change occurs in TBI, a form of ABI, 
it is likely that changes also occur in those living with other forms of ABI, such as 
stroke.   
IV. Stroke  
The Definition, Prevalence and Effects of Stroke  
A stroke results when the brain’s blood supply is blocked or when a blood 
vessel in the brain bursts106. The American Heart Association (AHA) estimates that 
someone in the US has a stroke every 40 seconds82. By 2030, nearly 4% of the US is 
projected to have experienced a stroke, and there will be an additional 3.4 million 
people with stroke compared to in 2012107. Stroke is the fourth leading cause of 
death106 and 80% of stroke can be prevented106. Maintaining a healthy diet and 
exercising are to ways to help prevent a stroke108. Eating five servings of fruits and 
vegetables per day has been found to lower risk of stroke by 30%108.  Additionally, a 
meta-analysis found those who had high physical activity levels had a 27% lower risk 
of stroke109.  Stroke occurs mostly in adults over the age of 657.   Women ages 55-75 
have a one in five chance of stroke, while male counterparts have a one in six 
chance110; each year approximately 55,000 more women than men have a stroke111. 
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Although age-specific stroke rates are high in men, women have much higher 
incidences at older ages due to the longer life expectancy in women112.  
  The total annual direct and indirect costs of stroke are forecasted to increase to 
$240.67 billion by 2030, an increase of 129%107.  Immediately following a stroke, at 
least 40% of stroke survivors have moderate disabilities and up to 30% have severe 
disabilities113.  A stroke may impact psychological, physical, social and cognitive 
function114.  These complications can alter a person’s life and increase risk of being 
institutionalized, becoming psychotic or depressed, or of dying114.   Of a 180 people 
over 65 years old, six months after stroke, 50% had hemiparesis, 46% had altered 
cognitive function, 35% had symptoms of depression, 30% were unable to walk 
without assistance, and 19% had aphasia19.  Similar to PD and TBI, side effects of 
stroke impact physical and cognitive function and may also lead to assistance with 
ADL115, as well as a decrease in dietary intake and quality overtime.  
Stroke and Effects on Cognition  
 
Cognitive-linguistic deficits following a stroke reduces functional outcome for 
at least five years after stroke in some individuals116. Assessments of cognitive-
linguistic function after stroke assess memory, information processing speed, 
visuoperceptual/construction ability, EF, attention, language and depression114,117. 
Impaired memory, poor concentration and mental slowness are the most common 
cognitive complaints after a stroke118,119. The functional status of 126 stroke patients 
was examined, (mean age 76.9 ± 10 years) at baseline (2-3 weeks after stroke) and 13 
months following event of stroke120. Findings concluded cognitive function at baseline 
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was an independent and significant predictor of long-term functional outcome and 
degree of disability after stroke120. 
Subjective cognitive complaints in 25 older adult stroke patients (mean age 
67±10 years) were assessed three to nine months after stroke and revealed 90% of 
participants reported cognitive issues or impairment4. Another study found attention, 
language, construction and reasoning the most affected cognitive limitations, where 
orientation was least affected121. Depression was the main variable that made a 
significant independent contribution to the prediction of subjective cognitive 
complaint4.  In general, cognitive decline, is associated with risk for functional decline 
in ADL122, which can impact dietary intake and physical activity level. Whether these 
cognitive issues in junction with physiological side effects of stroke impact dietary 
intake and physically activity level, as well as increases risk of reoccurring stroke 
must be assessed.  
Physiological Side Effects and Energy Needs of Stroke 
 Similar to TBI, the physiological side effects and impact of nutritional status 
during the acute phase of stroke has been thoroughly examined15,123.  Following a 
stroke the body is in a hyper-catabolic state, which increases energy needs15,16. These 
energy needs are usually not met and as a result, fat and muscle tissue wasting and 
weight loss occurs (Figure B)15. The body’s response to stroke leads to functional 
decline and the depletion of energy stores15. People who experience tissue wasting 
may also experience cachexia (dramatic weight loss and muscle wasting)124 or 
sarcopenia, which can contribute to a poorer prognosis after stroke15. 
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Figure B:  
          15 
 
Malnutrition and Stroke: Under-Nutrition  
 
In addition to weight loss from this hyper-metabolic state, persons in the acute 
phase of stroke are susceptible to weight loss due to fever, local central nervous 
system damage, and cytokines and oxygen-free radical build-up due damage of the 
blood vessel lining15.  Impaired feeding and dysregulation of appetite can also promote 
weight loss following a stroke15. Finally, inactivity due to paralysis, can promote 
weight loss due to a loss of lean muscle mass15,125, and severely interfere with one’s 
ability to prepare meals.  As a result, malnutrition can result from inadequate intake of 
kilocalories, protein and/or nutrients the body requires for maintenance and repair115.  
Malnutrition as a result of stroke can negatively impact physical and social well-being 
and quality of life126.  
Decline in nutritional status during the acute phase of stroke is highlighted in a 
prospective, descriptive study examining the risk and prevalence of malnutrition of 23 
participants123.  At baseline, 21 of 23 participants were considered well-nourished, 
however significantly more participants were malnourished or at risk of becoming 
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malnourished ten days later123. Based on MNA scores, after ten days, eight 
participants (35%) were well-nourished, nine (39%) were at risk of malnutrition and 
six (26%) were malnourished123. The MNA not only exams anthropometrics, but also 
includes a dietary questionnaire, as well as a global and subjective assessment. While 
MNA scores indicated decline in nutritional status, there was no significant change in 
weight and BMI scores between these two time periods123.  Despite a small sample 
size, this decline in nutritional status highlights rapid changes that occur during the 
acute phase of stroke.  
Impaired feeding during the acute phases of stroke can be due dysphagia, and 
up to 65% of people with stroke experience dysphagia126. Many regain functional 
swallowing usually within the first month following a stroke127, however, for some, 
dysphagia is still present six months after stroke128.  Dysphagia can compromise food 
and fluid intake, which can alter consciousness and promote physical weakness. The 
physical weakness experienced post-stroke can also negatively impact swallowing.   
Complications from dysphagia can also increase length of hospital stay, rehabilitation 
time, and result in a poorer long-term outcome126.  
Change in consciousness, difficulty swallowing, inadequate food and fluid 
intake, and an increased in energy expenditure as a result of stroke can result in severe 
malnutrition15,126.  Whether nutritional status improves or further declines after the 
acute phase needs to be more closely examined.  Since nutritional status is likely to 
decline in the acute stage, where there is closer monitoring over dietary intake, it is 
necessary to examine what happens to nutritional status in people with stroke as time 
progresses.  
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Westergren5 found stroke survivors who self-reported low energy levels, were 
more prone to poor nutritional status, since they may stop eating before daily energy 
needs are meet.  Research has examined nutritional status in the month following a 
stroke, and found chronic disabilities that interfere with ADL related to eating 
including purchasing groceries, preparing food, and eating5.  Eating difficulties, 
barriers that negatively interfere with the preparation and intake of food and fluids129, 
are common among stroke survivors and negatively impact dietary intake, as well as 
quality of life123,130. Eating difficulties (sitting position, managing food on plate, 
transporting food to mouth, opening and closing mouth, manipulating food in mouth, 
swallowing, food consumption, alertness and eating speed) related to stroke were 
observed. 
 A comparison of eating difficulties and nutritional status in the acute phase 
(the days immediately following stroke) was compared with nutritional status three 
months after stroke. The research found that majority of baseline eating difficulties, 
observed continued three months later. Inadequate food intake, increased in 22 
participants in the acute phase to 32 participants post intervention17.  Despite these 
observations, nutritional status, based on total MNA scores, significantly improved 
three months after a stroke17.  The contradiction of improved MNA scores compared 
to the observed inadequate food intakes, suggests nutritional status in those with stroke 
needs to be examined more thoroughly, and that the MNA may not be an effective tool 
in assessing nutritional status overtime in this population. 
 Other research has highlighted malnutrition to be an issue beyond the 
rehabilitation phase and up to six months after stroke compared to the acute 
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phase131,132. Six months after stroke 82% of women and 78% of men with eating 
disabilities did not meet energy requirements. Nutritional status, male gender, age, and 
stroke severity at admission were significant risk factors for poorer functional 
outcomes six months post-stroke16. Weight loss as little as three kilograms or more 
following a stroke has been an independent predictor of adverse outcomes following 
stroke133, this weight loss has been found to occur up to a year134.  As a result, 
malnutrition during acute stroke is considered a potentially modifiable factor that 
should be corrected and monitored to help improve long-term functional16. Whether 
weight loss continues to persist after a year following stroke must also be assessed, 
especially since many eating difficulties are associated with stroke135..  
Eating difficulties following a stroke highlights that individualized therapy 
after stroke to improve eating ability is imperative135. More research is needed to 
understand whether malnutrition persists a year or more after stroke, as well as 
preventing stroke reoccurrence.  Additionally, due to the susceptibility of malnutrition 
in the months following a stroke, an obesity paradox exists.  While, being 
overweight/obese increases risk of stroke, 22% and 64% respectively136, research has 
found an obesity paradox following a stroke137.  Being overweight or obese at the time 
of stroke seems to result in better long-term functional outcomes for those living with 
stroke137.  
 Malnutrition and Stroke: Over-nutrition  
 An obesity paradox seems to exist with stroke patients, in that mortality seems 
to be lower in obese patients137.   Those who are underweight at the time of stroke 
seem to have more complications and poorer survival than those who are of normal 
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weight or overweight when assessed six months after stroke138. The underlying cause 
of this paradox is currently unknown, but supported from research with large study 
populations139.   The notion of the obesity paradox and stroke is often attributed to the 
catabolic imbalances and inflammatory state immediately following a stroke that 
causes weight loss15.  This weight loss also causes muscle tissue wasting, which 
impairs recovery after stroke15.  
 While obesity increases risk of a first-time stroke, however, those who are 
overweight or obese post-stroke, are less likely to have a reoccurring stroke in the 
years following stroke139,140.   Through examining data form the Danish Stroke 
Registry, Andersen and Olsen140 found as BMI increases, the risk of a stroke 
reoccurring decreased, despite age, sex, stroke severity or cardiovascular risk profile. 
Underweight patients more likely had a history of a previous stroke140.  However, 
other research indicates, normal weight patients were more likely to have a 
reoccurring stroke24. This is a concern since research implicates compromised dietary 
intake in six months following129, which can promote a further decline in weight. 
 The obesity paradox seems to persist as time following a stroke progresses. A 
prospective study examined stroke survivors up to 30 months after stroke or a transient 
ischemic attack, and found overweight and obese participants to be at the lowest rink 
for the following endpoints: morbidity, mortality, and poor functional outcomes24. 
Those positive outcome measures were found the most in obese or very obese, while 
underweight participants were at the highest risk for all endpoints24.    
 Overall, existing research supports obesity paradox and stroke, however a 
recent study examining stroke rehabilitation outcomes, slightly contradicts the idea of 
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obesity paradox141.  The relationship between functional independence measurement 
(FIM) scores, including cognitive and motor sub-scores, and BMI scores for those in 
stroke rehabilitation was examined and those considered overweight had the highest 
motor and cognitive sub-scores141. There was no significance differences between 
motor FIM sub-scores between groups, but the overweight group had significantly 
higher cognitive sub-scores compared to the obese group141. No significant differences 
were found between normal weight stroke participants and underweight or overweight 
participants for cognitive sub-scores141. Whether this holds true beyond the 
rehabilitation phase has not been assessed, and highlights the need to develop proper 
guidelines for weight status and dietary intake following a stroke. Especially since 
research has found an association between obesity and poor cognition in the aging 
population142.  
 Due to mixed results, more research is needed understand how to help optimize 
health and prevent a reoccurring stroke or other forms of chronic disease. Research 
regarding the obesity paradox and stroke contradicts current guidelines to reduce body 
weight after stroke15, and clearer guidelines are needed to promote optimal weight 
status in this population, especially long-term (a year or more) after stroke. Stroke is a 
cardiovascular event, and as a result it is important to continue to assess the 
cardiovascular risk of this population to prevent the occurrence of another 
cardiovascular event. Due to the similarities this neurological condition has with TBI 
and PD, the cardiovascular health of these populations must also be examined.  
V.  Overall Cardiovascular Risk   
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 Across these three disease states research varies as to whether or not those 
living with neurological conditions such as PD, TBI and stroke are at increased CVD 
risk3,52,63,143 and this may be due to change in lifestyle following diagnosis as well as 
physiological impacts of the disease.  Cardiovascular disease is the leading cause of 
death in the United States144.  It is the disease of the heart and/or blood vessels and 
often results from atherosclerosis, which is the hardening of the arteries145. Modifiable 
CVD risk factors include being overweight or obese, having hypertension, elevated 
blood glucose levels, and dyslipidemia146. As well as life style choices such as 
physical inactivity, tobacco use and a diet high in saturated fat and processed foods 
and low in fruits, vegetables and fiber146,147.  
 To assess if one is overweight or obese, BMI and %BF are indicators.  
Body mass index is calculated from weight and height and can serve as an indicator of 
body fatness148.  Body mass index is classified according to predetermined categories: 
underweight = <18.5 kg/m2, normal weight = 18.5-24.9 kg/m2, overweight = 25-29.9 
kg/m2 and obese ≥ 30 kg/m2 148. According to the American Council on Exercise149, 
any female with ≥32% BF and any male with ≥25% BF are considered obese.  
 Blood pressure is a clinical risk factor for CVD. Systolic blood pressure (SBP) 
>120 mmHg and diastolic blood pressure (DBP) >80 mmHg are considered 
suboptimal. When diagnosing for metabolic syndrome, SBP >135mmHg and DBP 
>85 mmHg are used; these levels are considered pre-hypertensive150. Hypertension 
can be caused by lifestyle factors such as a high sodium diet, obesity and physical 
inactivity151. Suboptimal serum levels are also a risk factor for cardiovascular disease 
and can be affected by poor diet and physical activity152. Total serum cholesterol >200 
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mg/dL, low density lipoprotein cholesterol (LDL-C) >100 mg/dL, high-density 
lipoprotein cholesterol (HDL-C) < 40 mg/dL, and triglycerides  > 150 mg/dL are used 
to describe those with dyslipidemia153.  Dyslipidemia can lead hardening of the 
arteries overtime, which can lead to CVD154. Hyperglycemia is marked by fasting 
blood sugar > 100 mg/dL150 and can indicate insulin resistance, metabolic syndrome, 
pre--diabetes (110-125 mg/dL) or diabetes (>126 mg/dL)155.  
 The development of clinical and biochemical CVD risk factors are impacted by 
diet and physical activity.  An inverse relationship has been found with fruit and 
vegetable consumption and the risk of CVD147. Consuming fruits and vegetables >3 
times a day compared to once a day was associated with a 27% lower stroke 
incidence, a 42% lower stroke mortality, and a 27% lower cardiovascular disease 
mortality147. Increasing fiber intake, which can be found in fruits and vegetables and 
whole grain products, has also been found to reduce modifiable CVD risk factors such 
as dyslipidemia, diabetes and being overweight156-159.  Physical inactivity can also 
negatively impact blood pressure, lipid profiles, fasting blood glucose and weight, 
which in turn can lead to a cardiovascular event160.  
 In addition to modifiable risk factors that can increase risk of CVD, Non-
modifiable CVD risk factors include age, gender, race and family history145. Risk of 
developing heart disease increases with aging145.  Men are at greater risk of heart 
disease than pre-menopausal women, however once women are post-menopausal risk 
is similar across both genders145. African Americans seem to be at greater risk for 
developing CVD161. Finally, risk also increases if a first-degree relative had a 
cardiovascular event before the age of 55145. To assess and treat these risk factors, the 
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American Heart Association and American College of Cardiology developed 10-year 
and lifetime risk estimates using algorithms for the development of atherosclerotic 
cardiovascular disease (Figure C)162.  As described previously, those living with PD, 
TBI or stroke experience changes in physical and cognitive function3, which can not 
only impact nutritional status and dietary, but also promote a sedentary lifestyle, 
which may increase the risk of CVD in this population.  
 Research indicates those living with neurological conditions such as PD, TBI 
and stroke may be at increased CVD risk because they have one or more of these 
modifiable risk factors, such as a sedentary lifestyle, elevated lipid profiles or 
inadequate diets3,52,63,143. As described earlier, neurological conditions can impact 
dietary intake, especially for those living alone. Generally, older men living alone are 
at risk of malnutrition and need a supportive environment to provide optimal dietary 
intake and help compromise cardiovascular health163.   A recent study analyzed the 
daily eating events among older men living with PD, stroke or rheumatoid arthritis and 
found that men living alone used more convenience foods such as instant and ready-
to-eat foods, compared to those who lived with a significant other163. Convenient 
foods are often higher in sodium, sugar and fat compared to fresh, homemade meals 
and can increase risk for chronic disease, including CVD164.  
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 Figure C:        162 
1 
  
 While poor dietary intake may increase cardiovascular risk in those with stroke 
and PD, limited research exists regarding the dietary intake of those living with TBI.  
A late-onset complication of TBI is weight gain which can be a result from hormone 
and metabolic imbalances, as well as changes in mobility, self-regulation, altered 
satiety cues, and from medications that alter appetite3,86. Weight gain can lead to 
metabolic syndrome, which seems to develop in many of those living with TBI3.  
Metabolic syndrome is associated with excess food consumption, which can greatly be 
due to larger portion sizes, convenience foods and the availability of foods high in 
                                                 
1 Algorithm developed by The American Heart Association and American College of Cardiology to estimate 10-year 
and lifetime risks for the development of atherosclerotic cardiovascular disease (ASCVD) 
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saturated and trans fats and added sugars165,166. The prevalence of metabolic syndrome 
can also increase risk for the development of CVD in this population3. Yet, the 
prevalence of those with TBI who have CVD or may be at risk for CVD has yet to be 
assessed.  
 Meanwhile, the prevalence of overweight and obesity seems to change 
throughout the course of PD, depending on the stage of PD and side effects of 
medications1. Research has found a lower prevalence rate of stroke in those with PD 
compared to the general population167. The mechanism behind this is not fully 
understood.  There seems to be a higher prevalence of those overweight and obese 
with PD compared to the general population, however being overweight/obese with 
PD does not seem to increase risk for CVD168. While, research has found this 
association, the mechanism is still not quit understood, and as result monitoring 
weight is necessary to help prevent other declines associated with excessive weight 
gain.  
 Besides weight, research has also analyzed lipid profiles in those with PD. The 
relationship between cardio-metabolic risk factors and duration of PD has been 
examined to find that the longer one is living with PD, the better HDL-C levels are22. 
An inverse relationship of the TC-to-HDL-C ratio was also observed22.    Research has 
also examined the effect of lipid profiles on those with TBI. Hypopituitarism is a 
common side effect following TBI and those living with TBI and PTHP frequently 
present metabolic alterations that include altered glucose levels, insulin resistance and 
hypertriglyceridemia and dyslipidemia169. 
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 In a total risk assessment, patients with a TBI appear to be at significantly 
increased risk for stroke170, as well as diabetes mellitus, hypertension, atrial fibrillation 
and CVD3,16,89,170-172. Those with PTHP twelve months after TBI, had a higher total 
and LDL-cholesterol, as well as significantly higher BMI (23.9± 3.4 kg/m2 vs. 27.1± 
29.3 kg/m2), waist circumference (84±10 cm vs. 102±18cm) and total and abdominal 
FM compared to those TBI patients with intact pituitary function23. Mean BMI score 
for insufficient pituitary TBI patients increased significantly from three months to 12 
months following injury, from 27.1 kg/m2 to 29.3 kg/m2. Additionally, total 
cholesterol significantly increased from 174.1±46.4 mg/dL to 208.8 ± 27.1 in those 
with insufficient pituitary function104.  For those without PTHP, mean BMI scores 
remained stable and within normal limits, and total cholesterol levels saw a modest 
decrease23.  This study highlights the presence of cardiovascular risk in those with 
PTHP and TBI 12 months following injury, however what happens to weight status in 
TBI patients without and without PTHP beyond a year needs to be assessed.  
 When enough cardiovascular risk factors are present, this can lead to a 
cardiovascular event.  Traumatic brain injury is associated with increased risk of 
stroke, a population based study followed those living with TBI for 5 years after 
injury, and found TBI patients had 10.21 times, 4.61 times and 2.32 times greater risk 
of stroke compared to non-TBI patients at 3 months, one year and five years post 
diagnosis170. At three months following TBI diagnosis, 675 strokes occurred in those 
with TBI, while only 207 cases were reported in non-TBI patients170. This study 
speculates the increase risk of stroke in those with TBI can be from the disturbance of 
blood supply to the brain post TBI, the formation of an atherosclerotic blood vessel 
  
  
 
67 
due to the sudden impact after a TBI, or an increase in intracranial pressure and blood 
pressure post TBI170.  Antipsychotic drugs used to treat TBI may also increase risk of 
stroke173. The presence of cardiovascular risk factors previously described in this 
population3,23, as well as the role diet and physical inactivity plays in developing CVD 
risk factors may also increase risk of stroke. As a result a more thorough assessment to 
understand the relationship between TBI and a stroke event is warranted. Additionally, 
since both TBI and stroke are forms of ABI, the presence of CVD risk factors in TBI 
give warrant an examination of CVD risk n those living with stroke.  
 Whether those living with stroke remain at cardiovascular risk following event 
of stroke needs to be assessed. As described earlier, an obesity paradox seems to exist 
following stroke, and is associated with a decrease risk in stroke reoccurrence143.  The 
AHA proposed guidelines to prevent stroke reoccurrence, target similar modifiable 
and non-modifiable risk factors associated with CVD prevention174. The guidelines 
note that while obesity increases risk of stroke, no study has found weight reduction to 
reduce risk of stroke recurrence174. Additionally, Andersen and Olsen140 found patients 
with recurrent stroke are more often men, underweight and have a history of heart 
attack, atrial fibrillation, and hypertension. This study highlights the negative 
correlation between BMI and stroke recurrence based on an odds ratio (OR) (Figure 
D)140. It also highlights that risk factors for stroke and other cardiovascular events 
continue to exist in those following stroke if lifestyle modifications are not made.  
 A final modifiable risk factor that increases the chances of developing CVD is 
smoking tobacco.  Smoking increases risk for coronary heart disease and stroke by 
two to four times175; it can also reduce blood flow to legs and skin175.  The prevalence 
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of smoking amongst those with neurological diseases and the influence it has on 
cardiovascular health in this population needs to thoroughly be examined. In addition 
to lifestyle choices, such as smoking tobacco, physical activity and function are 
associated with cardiovascular risk. Due to the nature of these three diseases, physical 
activity level may be limited. Physical impairment can promote a sedentary lifestyle 
and weight gain, but also negatively impact lean body mass.  
 Figure D:  
140 
                  
 
VI. Physical Activity and Physical Function 
 Physical activity is bodily movement by the skeletal muscles that results in 
energy expenditure176.  It includes leisure time activities, such as sports and exercise, 
and ADL176.  Physical activity curtails risk of mortality and morbidity160. Health 
benefits of physical activity have been well documented, including weight 
management, and preventing and treating cardiovascular disease and musculoskeletal 
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disorders160. Physical activity promotes good physical health status, as well as mood 
and cognitive function, which can improve quality of life177. Evidence shows physical 
activity can help reduce age-related physical and cognitive decline178-180. A recent 
study examined the impact of a physical and leisure activity programmed on 
community-dwelling older adults and found the intervention had improvement in areas 
of cognition, specifically in abstract reasoning ability, a common initial symptom of 
dementia181, as well as significant in QOL.  
  Physical activity greatly relates to physical function, which is one’s ability to 
carry out tasks related to activities of daily living, as well as quality of life182. Limited 
physical function can be due compromised upper and lower extremity function122.   
Compromised physical function can interfere with performing different tasks such as 
walking, climbing stairs, lifting heavy objects, picking up an object off the floor183, 
bathing, dressing, eating and cleaning184. A decline in physical function may lead to 
sedentary behaviors, which combined with excess calorie intake, can increase risk for 
obesity185. Obesity is further associated with functional limitations186. 
  Many older adults develop sarcopenic-obesity, and this increase in body fat 
and decrease in muscle mass has been found to accelerate decline in physical 
function183,187.   To treat and prevent complications of sarcopenic-obesity, 
incorporating physical activity can increase muscle mass and decrease fat mass, and in 
turn enhance physical function188.  However, low BMI scores are also associated with 
compromised physical function, resulting in increased risk of falls and inability to 
carry out ADL189.  
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 Guidelines for physical activity have been created to promote optimal health 
benefits190.  The 2008 Physical Activity Guidelines for Americans190 recommends 
adults participate in at least 150 minutes of moderate-intensity or 75 minutes per week 
of vigorous activity.  This includes aerobic and muscle strengthening activity. Those 
living with chronic disease that follow physical activity guidelines can lower mortality 
by 46%, meanwhile adults without chronic disease following these guidelines can 
lower mortality by 27%191. The same guidelines pertain to those adults living with 
disability, including neurological disorders190. Research has found exercise to help 
lessen the burden of mobility related issues of PD192; those with PD who exercise have 
a better quality of life, walking ability, balance, strength, flexibility, and 
cardiovascular fitness levels192.   
 Despite these health benefits, some adults living with disability may not be 
able to meet these guidelines due to cognitive and physical impairment. For those 
living with disability, any degree of activity can provide health benefits and curtail 
functional decline193. Physicians can modify physical activity recommendations for 
those unable to meet guidelines193, but realities of these neurological disorders must be 
recognized to help this population overcome barriers of the disease that may deter 
participation in physical activity.  
 Physical and cognitive disabilities associated with neurological diseases can 
greatly impact physical function, which may decrease physical activity level and can 
also result in a decline in quality of life and depression3,4,39,194.  A decline in physical 
activity is a risk factor for decline in physical function and can further inhibit 
mobility122. Consequently, those living with PD, TBI or stroke are at risk for sedentary 
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behaviors and further induced functional decline, especially since these diseases can 
greatly impact movement of arms and legs185.  
  Motor and non-motor motor symptoms associated with PD may impact 
physical activity and function. .  A reduction in physical function can also reduce ADL 
such as housekeeping, preparing meals, and ability to travel in the community195. 
Additionally, Wild and colleague’s27 dual task study, revealed people with PD had a 
shorter gait due to difficulty with performing a cognitive task in conjunction with a 
motor task.  Additionally, those with PD that had postural instability and gait 
difficulty reported worse health-related quality38.  Changes highlight the impact both 
motor and non-motor symptoms have on PD, resulting in life-style changes.  
 Physical and cognitive changes experienced in this population may also 
increase risk for falling. Falls not only impact well-being, but can result in severe 
injuries196.  Factors that increase risk for falls include older age, body composition, 
number of chronic diseases, muscle strength, functional mobility, balance, and fear of 
falling197-199.   Targeting these risk factors by promoting physical activity that targets 
muscle strength and balance may help to prevent falls in this population, as well as 
those with other neurological disorders.  
 Extensive research indicates those with PD and stroke are at increased risk for 
falls200,201.  Approximately 60% of those living with PD fall yearly202.  Predicting falls 
in those with PD are associated with history of previous falls, disease severity, poor 
balance, reduced mobility, freezing of gait and reduced leg strength203,204.   Similar 
physical limitation following a stroke also increase risk of falling205, and it is one of 
the most common complications following a stroke206. 
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  Following a stroke, impaired dynamic balance is associated with frequent falls 
three weeks after stroke205. Those who experience falling after a stroke show lower 
cognitive and physical functions, compared to those who did not fall, which highlights 
falling may impact cognitive and physical function205.  This loss of balance, combined 
with fear of falling, may promote a sedentary lifestyle and decline in physical activity 
level. 
  Additionally, immediately following a stroke, walking dysfunction is 
common, as well as fatigue and lack of energy5. To treat these symptoms rehabilitation 
is usually followed after a stroke. Research also reveals rehabilitation post stroke is a 
key time to assess cognitive function, and that stroke-related cognitive impairment can 
limit functional gains during stroke rehabilitation200. Also, despite rehabilitation 
physical limitations can persist or re-occur20,130. Six months following a stroke, among 
206 participants, 75% experience upper limb/motor impairment130. Research has also 
found three to nine months following a year-long rehabilitation, those living with 
chronic stroke seem likely to redevelop symptoms of walking dysfunction207-209. 
Additionally, research has found gait seems to worsen in the later years post stroke20, 
which can present challenges with balance, an increase in energy expenditure, risk of 
injury and decrease activity levels20.  These findings insinuate rehabilitation exercises 
beyond the rehabilitation phase may be necessary to promote and maintain optimal 
physical function in those living with chronic stroke.  
 The literature also implies those living with TBI may be at increase risk for 
falling3,7. This can be due to changes in strength, endurance and balance210, as well as 
diminished motor-planning and attention, pain and weight gain3. All of these factors 
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are inter-related and can promote poor physical function and low physical activity 
levels. While a decline in mobility is a part of the natural aging process, it seems to 
happen more rapidly in those living with TBI3.  
 Those who sustain a TBI are also more likely to experience muscular and 
orthopedic symptoms compared to nondisabled people86. Change in mobility, pelvis, 
limb and vertebrae fractures and other physical traumas that occur at the time of injury 
can also have long-term consequence and can re-emerge overtime, thus decreasing 
physical function and activity level and promoting weight gain3. Pain and stiffness in 
the joints may also deter physical activity in this population3.  If this population 
continues to be sedentary and obesity develops, pain can become more pronounced, as 
research has found an association between obesity and joint and muscle pain211. Since 
over-nutrition has also been found in those with PD and stroke these issues may also 
occur in these neurological disorders as well.  
 As previously described, those with PD, TBI or stroke can suffer from under- 
and over-nutrition. As a result, both physical inactivity and being obese are associated 
with decline in physical function and associated risk factors, such as the development 
of metabolic syndrome, CVD, and diabetes193. Being underweight can result in muscle 
wasting and poor physical function18. As previously described those with disability 
that are underweight may have issues with eating and swallowing which can also 
promote decline in physical function129.   
 Issues of physical function are prevalent in all three of these disease states and 
can further negatively impact health and quality of life. While, functional decline is a 
natural part of aging, it is more severe for those living with neurological conditions 
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and other chronic diseases193. A recent cohort study examined factors associated with 
changes in physical function in older Chinese adults and found the main cause of 
functional decline was chronic disease; older persons with chronic conditions, such as 
stroke, PD, diabetes, and osteoporosis were more likely to experience a decline in 
physical function over the four year study period193.   This study highlights that while 
chronic diseases increase the likelihood of disability, information regarding effective 
management of these disabling conditions is limited193,212.  Research has also yet to 
examine the role of combining nutrition, cognition and physical activity in this 
population and how it can positively improve health outcomes.  
 Cognitive decline associated with these disease states can also impact physical 
activity level and physical functioning.  Even mild levels of cognitive impairment 
have been found to increase disability and overall functional impairment10.   Those 
with cognitive impairment may not be able to effectively perform meaningful tasks, 
which is hypothesized to be closely linked to inability to carry out ADL213. Besides 
poor cognition, psychological issues associated with these neurological disorders, 
including fear of falling is recognized as a factor that may deter older adults 
susceptible to falls from being physically active198.   
 While existing barriers can lead deter physical activity and promote decline in 
physical functioning, certain factors in this population have been found to help curtail 
this decline. A recent study examining factors that impact exercise behavior of 260 
participants living with PD contradicts this214. The study found that those who 
participated in exercise had less severe motor impairment, fewer depressive 
symptoms, and few issues with physical mobility. Through a multivariate logistic 
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regression, this cross sectional study found the degree of physical impairments, 
activity limitation and participation restrictions were not significantly associated with 
exercise behavior, but self-efficacy and belief regarding capabilities to exercise 
were214.  
 Regardless of disease severity, those with higher self-efficacy were more than 
twice as likely to participate in routine exercise compared to those with low self-
efficacy214. A higher education level and older age also was associated with increased 
likelihood to partake in exercise214.   The majority of participants (86%) had mobility 
related issues that disabled them from participating ADL, but 88.8% of participants 
had a social support system at home to assist them214. This highlights that the main 
source of physical activity for this population is from planned exercise and leisure 
activity, as opposed through independently carrying out ADL. Findings also imply 
that promoting an increase activity in this population may be most effective through 
encouraging exercise and leisure time activity.  
  A limitation of this study was that the majority of participants only had mild-
to-moderate PD.  Additionally, due to the cross-sectional study design, causality as to 
whether exercise promotes high self-efficacy or high self-efficacy promotes exercise 
needs to be monitored overtime214. How the progression of the disease impacts self-
efficacy, willingness to exercise overtime, and whether exercise overtime can help 
delay the progression of the disease must also be assessed214.   
 Never the less, the findings of Ellis and colleagues214, reveal an understanding 
of factors that promotes physical activity can help provide vital information on how to 
promote physical activity and provide clearer recommendations for those living with 
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neurological disorders. Physical inactivity can result in a further decline in physical 
function.  Decline in physical function can promote muscle loss, as well as a decline in 
quality of life. While research has identified barriers that may promote a sedentary 
lifestyle, research has not examined the physical activity level of those living with one 
of these neurological conditions overtime. Doing so will help understand how and why 
ability to participate in exercise changes overtime. An assessment of physical activity 
levels and physical function of this population overtime can provide a better 
understanding of the diseases, and help create clearer recommendations and 
specialized programs for individuals throughout life.  Doing so will not only decrease 
risk of developing other comorbidities associated with a sedentary lifestyle, but also 
help improve quality of life160.  
VII.  Quality of Life   
 The World Health Organization (WHO) defines quality of life (QOL) as one’s 
perception of their position in life in relation to the culture and value system in which 
they live215.  The long-term disabilities of these neurological diseases greatly impact 
QOL3,4,58. Quality of life has been shown to be lower in those with PD compared to 
age-matched healthy controls as well as compared to those with other disease entities 
such as diabetes216. A recent study, examined resilience, or one’s ability to “bounce 
back” following an event or diagnosis, in those with PD. Results found that those with 
higher resilience scores, had better physical and mental quality of life and lesser 
disability217. However, no correlation was found between disease severity and 
resilience scores217. Depression and mild cognitive impairment in those with PD is 
also correlated with a poorer nutritional status, indicating a worse QOL1,36,68,69. Those 
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living with TBI and stroke also experience mental and physical side effects, which can 
also experience changes in QOL72.  
 Those with TBI often experience side-effects that compromise well-being, 
such a bowel and bladder incontinence, sleep disorders, psychiatric diseases and 
sexual dysfunction218. Additionally, Siponkoski and colleagues219 examined the 
quality of life of those with TBI that received intensive multidisciplinary residential 
rehabilitation treatment for up to 15 years post injury, and found quality of life was 
related to age at time of injury, depression, anxiety, amount of assistance needed, and 
education level219.  Results also found that QOL remained stable over time and that 
those with milder injuries had a lower QOL219.   Traumatic brain injuries can impact 
long-term functional outcomes in older adults, however more information is needed to 
identify the specific, long-term post TBI side effects have on ADL, especially in older 
adults28.  Jacobsson and Lexell220 examined life satisfaction in those living with TBI 
six to fifteen years after injury and found those with a higher life satisfaction had 
fewer emotional disturbances and better social participation, as well as a longer time 
post injury and a more severe injury sustained later in life.  It appears cohabiting and 
higher productivity levels also helps improve life satisfaction220. Findings indicate life 
satisfaction can improve with time and highlight factors that can impact life 
satisfaction.  Both studies indicate more severe cognitive impairment seems to be 
associated with greater QOL and life satisfaction219,220.  The reasoning for this, as well 
as the impact disease severity has on other health parameters, needs to be further 
investigated.   
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 Quality of life is also impacted in those with stroke, which can be exhibited by 
eating difficulties and inability to perform activities of daily living5. Research also 
consistently finds women seem to have less favorable outcomes after stroke than 
men, more difficulty with ADL, depression and overall lower QOL112.  This lower 
QOL in women could be due to worse mobility, pain/discomfort, and anxiety and 
depression observed up to 12 months after stroke221.  Research suggests that quality 
of life is often compromised in those living with PD, TBI and stroke, and as a result 
depression is a common side-effect of those living with one of these neurological 
conditions38,37,219.  Fatigue and sleep disturbances are common side effects of these 
three neurological conditions that can greatly impact quality of life86.  A decline in 
quality of life can negatively impact nutritional status, as well as physical activity and 
function.  
VII.  Conclusion  
 Parkinson’s disease, TBI and stroke are three neurological diseases that impact 
cognitive and physical function as well as nutritional status and risk of CVD. Research 
suggests dietary intake and nutritional status can be compromised due to the 
complications of these neurological conditions3,16,65. How nutritional status and 
physical activity level are impacted a year or more after diagnosis in those living with 
one of these diseases must be assessed to understand the difference between each 
disease and to acquire an understanding in treating those living long-term with PD, 
TBI or stroke.  Assessing how nutritional status and physical activity level impact risk 
for cardiovascular disease, physical function and quality of life must also be assessed.  
Due to the prevalent research of weight loss and eating difficulties associated with one 
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of these neurological disorders, research also indicates those living with neurological 
conditions may be at risk for malnutrition1,13-16 a year or more after diagnosis. It is 
necessary to examine how disabilities increase rate of nutritional and cardiovascular 
risk.  It is also necessary to examine how cognition, nutrition and physical functioning 
interact in those living with neurological disorders and impact quality of life.  
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Appendix B: Extended Methodology 
Subjects 
Twelve participants were included in the study and consisted of eight males 
and four females between ages 33 and 71. At baseline, a total of 15 subjects were 
recruited. Participants were eligible if they were diagnosed with Parkinson’s disease 
(PD), traumatic brain injury (TBI) or stroke for at least 12 months and were between 
the ages of 18 to 85. Participants were required to have a means of transportation to 
one of the URI Speech and Hearing Clinic locations.  
This research was conducted as a sub-study of a longitudinal, observational 
study examining the cognition, nutritional status, physical activity level and physical 
functioning of those living with neurological disorders. Both received approval from 
URI’s Institutional Review Board (IRB), Longitudinal Study of Communication, 
Nutrition and Physical Activity, IRB HU1314-006. Participants were recruited via 
announcements, brochures, and word-of-mouth. Brochures were provided to physician 
offices, hospitals, rehabilitation centers and health professionals to aid in recruitment 
as well as to those clients participating in URI’s Department of Communicative 
Disorder’s LOUD Crowd and Gateway Wellness Café. Study staff explained the 
research project to potential participants. If a potential participant was eligible and 
interested, they signed two copies of an informed consent. This sub-study only 
included baseline assessments, but participants consented to participate in a five-year 
longitudinal study with assessments every six months. Participants were then assigned 
identification numbers for data management that did not include any identifying 
numbers or letters. 
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The study utilized baseline data collected from November and December 2013. 
Written data was stored in a locked file cabinet in 203 Fernwood on the URI campus. 
Electronic data with identified information was stored on a computer in 203 Fernwood 
and password protected and encrypted. De-identified data sets (identifying information 
like name address, email and telephone numbers removed) were stored on password -
protected computers in Ranger 301 (Lofgren’s lab) and 214 Independence Square 
(Delmonico’s lab).  
Protocol Overview 
Participants reported to a URI Speech and Hearing Clinic location for baseline 
assessments. Baseline assessments were conducted on two separate occasions. After 
signing informed consent, participants completed cognitive, nutrition, and physical 
function assessments.   Participants fasted 12-hours prior to the assessment, but were 
encouraged to drink water during this fast. During the assessment, a 12-hour fasting 
blood sample was collected, as well as blood pressure. Nutritional status was 
examined using assessment tools that reflect dietary quality, anthropometrics, body 
composition and biochemical values. 
All questionnaires were administered to participants by study staff. The 
following surveys related to cognitive-linguistic capacity, nutrition and physical 
functioning and physical activity were completed: The Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS)1, the Swallowing Quality of Life 
Survey (SWAL-QOL)2,3, the Dietary Screening Tool (DST)4,5, and Physical Activity 
and Disability Survey (PADS)6,7. Other questionnaires included: a medical history 
questionnaire, 14-item Resilience Questionnaire8,9, and the Satisfaction with Life 
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Scale (SWLS)10,11.  To assess physical function the short physical performance battery 
(SPPB)12 and the timed up and go (TUG)13 test was used. Assessments took 
approximately 3 ½ hours to complete per participant.  
Anthropometrics 
Trained study staffed obtained all measurements using standard procedures. 
Height (cm) and weight (kg) were measured using a stadiometer (Webb City, MO, 
USA). Height was rounded to the nearest 0.5 cm and weight was rounded to the 
closest 0.1 kg.  Height and weight value was used to calculate BMI (kg of body 
weight/height in meters2). Body mass index was classified according to predetermined 
categories: underweight <18.5 kg/m2, normal weight = 18.5-24.9 kg/m2, overweight = 
25-29.9 kg/m2 and obese ≥ 30 kg/m2 14.  
A foot-to-foot bioelectrical impedance analysis device (Tanita BF-556, 
Arlington Heights, Illinois) was used to obtain body composition. This is a portable, 
battery-operated device that uses a very low electrical current (battery powered, 50 
kHz) to estimate fat mass and percentage body fat.  This test is a valid and reliable tool 
to measure body composition15. According to the American Council on Exercise16, 
any female with ≥32% body fat and any male with ≥25% body fat was considered 
obese. Even though risk for this test is minimal, participants with a pacemaker were 
not tested.  
Biochemical Markers 
Serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), triacylglycerol (TRG), and glucose were 
obtained using a finger stick (Cholestech® LDX system, Hayward California).  Prior to 
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obtaining blood markers, participants were instructed to abstain from eating or 
drinking for 12 hours.  However, unlimited water intake was permitted and 
encouraged during the 12 hour fast.  Forty microliters of blood was drawn from the 
participant’s finger by trained personnel using a lancet, collected into a capillary tube, 
put into a cartridge, and assayed using the portable Cholestech® (LDX system, 
Hayward California) machine.  The study staff used universal precautions and 
standardized protocols. Participants with total serum cholesterol <200 mg/dL, LDL-C 
< 100 mg/dL, HDL-C > 40 mg/dL, and TRG < 150 mg/dL will have a serum lipid 
panel within normal limits17.  A clinical diagnosis of high biochemical values include 
TC >240 mg/dL, HDL-C <40 mg/dL, LDL-C >160 mg/dL, and TRG >20017. Fasting 
blood glucose <100mg/dL was considered normal, 100-125mg/dL impaired, and > 
126mg/dL was considered high.  
Blood Pressure 
 Trained study staff measured blood pressures18. Participants sat quietly for five 
minutes and the cuffed arm was supported at heart level. Blood pressure was measured 
using an automatic blood pressure machine (Omron Healthcare Inc., Bannockburin 
Illinois).  Blood pressure was taken twice or until readings were within 2 mg/dl and 
the readings were averaged together.  Systolic blood pressure <120mmHg and 
diastolic blood pressure < 80 mmHg were considered within normal limits.  Systolic 
blood pressure > 130 mmHg and diastolic blood pressure > 85 mmHg were considered 
borderline high, while SBP >140mmHg and DBP >90 mmHg was considered 
hypertensive.  
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Questionnaires  
Due to cognitive difficulties, the described questionnaires were to chosen to 
decrease labor intensity for the population of interest. To reduce error and inaccuracy, 
short questionnaires validated in elderly populations, neurological conditions or 
physical disabilities were selected. 
Cognitive-Linguistic  
To measure attention, language, memory, constructional and visual-spatial 
abilities, the RBANS was used1. It includes 12 subtests, with five index scores, 
summarizing: immediate memory, visuospatial/constructional, language, attention and 
delayed memory. The total score is the sum of all the index scores. Scoring is based on 
a mean of 100 and a standard deviation of 15, and a score <70 indicates suboptimal 
cognitive function.  The test takes approximately 30 minutes to complete and is 
intended to assess adults ages 20-89. 
Swallowing Evaluation 
The SWAL-QOL is a 44-item survey where participants rate factors about 10 
quality of life concepts related to swallowing2,3. Specifically, participants were asked 
how swallowing problems affect their daily lives, especially in regards to eating and 
diet2,3. The highest possible score is 220, the higher the score the better one’s 
swallowing function.  The SWAL-QOL took approximately 10 minutes to complete.   
Dietary Quality & Nutrition Risk Assessment 
 Participants completed the DST. This 25-item questionnaire is used to identify 
dietary patterns and nutritional risk in older adults4,5. Participants reported how 
frequently they consumed a food or type of food, as well as different dietary practices. 
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The sub-components and point distribution included: whole fruit and juices (15 
points), vegetables (15 points), lean proteins (10 points), Added fats, sugars and 
sweets (25 points), dairy (10 points) and processed meats (10 points), and use of a 
dietary supplement (5 points).  
Based on these responses a composite score was calculated and correlated with 
three different nutritional risk levels; (<60) at risk, (60-75) possible risk, and (>75) not 
at risk4.  Categorization into three nutritional risk categories provides a way to 
determine if a patient needs a follow-up or nutrition assessment4.  The DST Dietary 
intake was broken down based on point classification for the DST sub-components4 to 
explore specific areas contributing to low dietary quality. These sub-components were 
created to identify specific areas of the diet that may be problematic on an individual 
basis4. Cut points were set based upon if the participant had a score of approximately 
50% or less of possible points for each sub-component. Participants with fewer than 
50% of total possible points for each sub-component and if the participant did not 
currently take dietary supplement were considered low sub-scores. Less than 50% was 
selected as an exploratory marker to indicate infrequent/inadequate intake of whole 
grains, fruits, vegetables, dairy or lean proteins, and high consumption of processed 
meats, added sugars, fats and sweets. 
This survey took approximately 10-15 minutes for the study staff to complete 
with each individual participant. While the DST has not been validated in those living 
with neurological disorders, it has been validated in older adults and is a capable of 
characterizing the overall dietary patterns of the older adult population4.  
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Physical Activity Survey 
The PADS was used to measure activity level. This survey is a validated and 
reliable source to measure physical activity in those who are sedentary and 
disabled6,19. This tool covers a wide range of activities and includes six sub-scores: 
exercise, leisure-time physical activity (LTPA), general activity, therapy, employment, 
and wheelchair use. Scores increase as physical activity increases. The PADS is coded 
based on intensity, type and amount of activity, and can detect varying levels of 
physical activity19. Raw scores of 0-27 indicate minimal, 28-42 is minimal to 
moderate, 43-67 is moderate, and > 68 indicates an extreme level of activity6. This 
survey took about 20 minutes complete.  
Physical Functioning Assessment  
The SPPB12 was completed to assess participants’ global physical functioning 
and included timed measures of usual gait speed, standing balance tests, and repeated 
five chair stands. For the balance tests participants were asked to maintain their feet in 
side-by-side, semitandem, and tandem stances for 10 seconds each. To assess walking 
speed participants walked four meters at their usual pace. Walking speed was 
performed twice, and the faster time was recorded. During the chair test participants 
stood up from sitting position with their arms folded across their chest. If the 
participant were able to perform this task, they were instructed to stand up and sit 
down five times as quickly as possible. The time to perform this task was recorded.  
SPPB scores are reported out of 12, and each sub score ranges from zero to four, and 
the higher the score the better lower physical function. Scores 8-12 are considered 
“high functioning12. 
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 A timed up and go (TUG) test was used to assess basic functional mobility13.  
It measures the time it takes for the participant to raise from a chair, walk three meters, 
turn around and walk back to the chair. The shorter amount of time, the better the 
score. Time was recorded in seconds, the test was administered twice and the better 
score was recorded. Those with TUG scores >13.5, are considered high risk for falls20 
Other Questionnaires  
Past Medical History Questionnaire 
To identify health-related conditions and how these conditions may impact 
health, a non-validated medical history questionnaire will be used. Topics covered will 
include neurological, endocrine and cardiovascular health. Ten minutes were allotted 
to recite and complete this survey for each participant.  
Resilience  
The 14-item Resilience Scale8,9 measured resiliency.  Resiliency is one’s 
ability to recover from a physiological or psychological event8,9. It is a validated and 
reliable tool that has found a significant correlation between resilience, morale, 
depression and overall life satisfaction in older adults9.  Questions are answered on a 
Likert scale from one to seven, where participants reflect on their belief that their life 
has meaning, sense of uniqueness, and ability to exist alone and manage their lives; 
higher scores are associated with greater degrees of resiliency8,9. It took approximately 
five minutes to complete. Total possible scores range from 14 to 98, and a higher score 
indicates higher levels of resilience.  
Life Satisfaction 
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The SWLS, a five-item questionnaire, was used to obtain overall life 
satisfaction10.  It is used to measure global life satisfaction by asking participants to 
make a broad judgment of their life10. This questionnaire is answered on a Likert scale 
that ranges from one to seven10,11. Total possible score ranges from five to 35, and the 
higher the score, the greater life satisfaction.  
Cardio-Metabolic Assessment  
Cardio risk factors were selected, and grouped into eight categories based upon 
modifiable and non-modifiable risk factors. These eight selected categories included: 
1.) age (>45 years for men, >55 years for women), 2.) anthropometrics (BMI, %BF) 
3.) clinical (SBP and DBP), 4.) biochemical (TC, HDL-C, TC/HDL-C ratio, LDL-C, 
TRG and Glucose), 5.) diet (DST scores), 6.) physical barriers (use of legs, arm or 
assistive device), activity (PADS scores) and functioning (SPPB and TUG scores), 7.) 
smoking status, and 8.) cognition (RBANS scores). Those living with neurological 
disorders suffer physical and cognitive impairment that may disrupt activities of daily 
living (ADL); as a result physical barriers (such as partial or no use of arms and legs, 
as well as use of an assistive device) were examined due to the possibility they may 
promote a sedentary lifestyle. Cognitive function was also included as a CVD risk 
factor through examining total RBANS scores and three RBANS index scores 
(immediate memory, attention, delayed memory) <70.   
 
Statistical Analysis  
This is the first analysis of this study, and therefore statistical analysis were not 
hypothesis driven, but conducted to generate hypothesis and explore the population. 
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Collected data was analyzed using SPSS, version 22.0 for Windows (IBM Corp.  
Summers, NY). Descriptive statistics were conducted and distribution of data was 
assessed through analyzing skewness and kurtosis. For data that was not normally 
distributed, proper statistical methods were used to account for this. Categorical 
variables are represented as numbers and percentages and continuous variables are 
reported as mean ± standard deviation. 
To analyze CVD risk factors, the participants were individually analyzed 
across the eight categories.  The most frequent risk factors were then analyzed based 
on the variables within the eight CVD categories and reported as top CVD risk factor.
  For all normally distributed data, independent t-tests were conducted to 
determine if there were significant differences between groups regarding assessment 
variables. Cohen’s d was calculated to describe effect size for differences between 
groups in normally distributed variables (0.2 = small effect, 0.5 = medium effect, 0.8 = 
large effect). For data not normally distributed, Mann-Whitney U tests were used to 
analyze differences between groups and effect size was signified through calculating r 
(0.1 = small effect, 0.3 = medium effect, 0.5 = large effect).  Between group 
differences for categorical variables were identified using Fisher Exact Tests. Phi 
coefficient or Cramer’s V were used to signify effect size (0.1 = small effect, 0,3 = 
medium effect, 0.5 = large effect). Pearson’s R Correlations were used for normally 
distributed variables, and Spearman Rho Correlations were used as the non-parametric 
alternative.  Significance for all analyses was set at p <0.05.  
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Power Calculation 
An A-priori power analysis found that a sample of 28 PD participants and 14 
ABI participants would find significant difference between groups and SPPB scores. 
To find significant differences between groups and DST scores, an A-priori power 
analysis suggests 63 PD participants and 31 ABI participants are needed. 
Resources Required  
Funding for this research was provided by URI’s Department of 
Communicative Disorders. Supplies provided by the Department of Nutrition and 
Food Sciences included: computers, printers, computer software, paper and physical 
assessment equipment. Personnel to conduct the study were supplied by the 
Departments of Communicative Disorders, Kinesiology, and Nutrition and Food 
Sciences. No other university resources will be required for this study. 
 
References 
1. Randolph C. Repeatable Battery for Assessment of Neurophyschological 
Status. Examiner's Manual San Antonio, TX: The Psychological Corporation 
1998. 
2. McHorney CA, Martin-Harris B, Robbins J, Rosenbek J. Clinical validity of 
the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow 
measures. Dysphagia 2006;21:141-8. 
3. McHorney CA, Robbins J, Lomax K, et al. The SWAL-QOL and SWAL-
CARE outcomes tool for oropharyngeal dysphagia in adults: III. 
Documentation of reliability and validity. Dysphagia 2002;17:97-114. 
4. Bailey RL. Dietary screening tool identifies nutritional risk in older adults The 
American Journal of Clinical Nutrition 2009;90:177-83. 
5. Bailey RL, Mitchell DC, Miller CK, et al. A Dietary Screening Questionnaire 
Identifies Dietary Patterns in Older Adults The Journal of Nutrition 2007; ;137: 
:421-26. 
  
  
 
109 
6. Kayes NM, McPherson KM, Taylor D, Schluter PJ, Wilson BJ, Kolt GS. The 
Physical Activity and Disability Survey (PADS): reliability, validity and 
acceptability in people with multiple sclerosis. Clin Rehabil 2007;21:628-39. 
7. Kayes NM, Schluter PJ, McPherson KM, Taylor D, Kolt GS. The Physical 
Activity and Disability Survey -- Revised (PADS-R): an evaluation of a 
measure of physical activity in people with chronic neurological conditions. 
Clin Rehabil 2009;23:534-43. 
8. Wagnild GM. The Resilience Scale User's Guide. 2009; 
http://www.resiliencecenter.com. 
9. Wagnild GM, Young HM. Development and psychometric evaluation of the 
Resilience Scale. J Nurs Meas 1993;1:165-78. 
10. Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. 
J Pers Assess 1985;49:71-5. 
11. Pavot W, Diener E, Colvin CR, Sandvik E. Further validation of the 
Satisfaction with Life Scale: evidence for the cross-method convergence of 
well-being measures. J Pers Assess 1991;57:149-61. 
12. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance 
battery assessing lower extremity function: association with self-reported 
disability and prediction of mortality and nursing home admission. J Gerontol 
1994;49:M85-94. 
13. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional 
mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-8. 
14. Center for Disease Control and Prevention: About Adult BMI. . 2011; 
http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html. 
Accessed May 2, 2013. 
15. Ritchie JD, Miller CK, Smiciklas-Wright H. Tanita foot-to-foot bioelectrical 
impedance analysis system validated in older adults. J Am Diet Assoc 
2005;105:1617-9. 
16. American Council on Exercise. Percent Body Fat Norms for Men and Women. 
2013; 
http://www.acefitness.org/?creative=45247336884&device=c&network=g&ma
tchtype=b&gclid=CNi3ieq6jr0CFcFlOgodCVAAxQ. Accessed June 2, 2013. 
17. Centers for Disease Control and Prevention. Cholesterol 2012. Accessed April 
3, 2013. 
18. Centers for Disease Control and Prevention. High Blood Pressure 2013; 
http://www.cdc.gov/bloodpressure/. Accessed May 13, 2013. 
  
  
 
110 
19. Rimmer JH, Riley BB, Rubin SS. A new measure for assessing the physical 
activity behaviors of persons with disabilities and chronic health conditions: 
the Physical Activity and Disability Survey. Am J Health Promot 2001;16:34-
42. 
20. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls 
in community-dwelling older adults using the Timed Up & Go Test. Phys Ther 
2000;80:896-903. 
 
 111 
 
 
Appendix C: Consent Form for Research 
Longitudinal Study of Communication, Nutrition and Physical Activity 
 
Leslie A. Mahler, PhD, Principal Investigator 
Ingrid Lofgren, PhD, co-Investigator 
Matthew Delmonico, PhD, co-Investigator 
 
CONSENT FORM FOR RESEARCH: Participant 
Version 2: July 30, 2013 
 
The University of Rhode Island 
Department of Communicative Disorders 
25 W Independence Square, Suite I 
Kingston, RI 02881 
 
Purpose of the Consent: 
You have been invited to take part in a research project described below.  The purpose 
of the consent form you are about to read is to provide you with details about the 
research study and to inform you of your rights if you agree to participate in the study.  
Your participation is completely up to you.  The researcher will explain the project to 
you in detail.  You should feel free to ask questions.  If you have more questions later 
you can call, Dr. Leslie Mahler, the person mainly responsible for this study, at 401-
874-2490.  You may also contact Dr. Ingrid Lofgren at 401-874-5706 or Dr. Matthew 
Delmonico at 401-874-5440, who are co-Investigators on the study.  You must be at 
least 18 years old, speak English, and have neurological diagnosis of traumatic brain 
injury, stroke, or Parkinson disease to be in this research project. 
 
Description of the project: 
This is a research project designed to look at communication, nutrition, and physical 
activity characteristics of adults who have a stroke, traumatic brain injury or Parkinson 
disease.  All evaluations will be conducted at one of two University of Rhode Island 
locations; in Independence Square on the Kingston Campus at 25 West Independence 
Way, Kingston or in Independence Square at 500 Prospect Street in Pawtucket.   
 
You are being asked to be in this study because we want to determine the long-term 
impact of neurological disorders on communication, nutrition, and physical activity. 
We are looking for 200 people who have a stroke, traumatic brain injury or Parkinson 
disease to participate in this project.  Participation in this study is entirely your choice. 
 
If you decide to take part in this study, you should understand that the evaluations are 
investigational and you may not experience any benefit from participation.  
Participation may also involve additional risks as listed in the Potential Risks and 
Discomforts section. The consent form will help make sure you understand the tasks 
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included in the study before you decide whether you want to take part in the study.  
You may also quit the study at any time. 
 
What will be done:  
If you agree to take part in this study, you will be asked to complete up to 11 
evaluations over five years.  Evaluations will take place every six months.  The 
evaluations will include a variety of tasks such as reading sentences and describing a 
picture, an assessment of how your muscles move, a cognitive screening, an interview, 
a clinical swallowing evaluation, and questionnaires regarding swallowing, diet and 
physical activity.  The total time for each evaluation will be approximately 3½  hours.  
All evaluations will be conducted in a quiet private room at one of the University of 
Rhode Island Speech and Hearing Clinic locations (Kingston or Pawtucket). 
 
With your permission, we will request health information from your physician about 
the following specific items only: 
 Date of diagnosis 
 Current medications 
 Imaging information about where the brain damage is located (if 
appropriate) 
You will sign a separate form to indicate whether you give your permission to 
release this health information for the study. 
 
Potential risks and discomforts: 
There are minimal foreseeable risks associated with these evaluations. There have 
been no reported adverse affects from clinical evaluation of speech and swallowing.  
There may be some unknown or unanticipated risks, but every precaution will be 
taken to ensure your personal safety.  Even though experienced personnel will obtain 
the blood samples from a finger prick, there is a chance of discomfort and minor 
bruising from the finger stick.  For physical function testing there is a risk of muscle 
soreness or other muscle injury as well as skeletal injury but we will minimize these 
risks by using standard safety practices. 
 
Purpose and benefits of the study: 
The purpose of this study is to describe communication, nutrition, and physical 
activity behaviors over time to see how they change and affect quality of life.   The 
information obtained is important because it will help us to understand how to provide 
services to meet the needs of people with neurological diagnoses.  This is an 
investigational study and there is no guaranteed benefit to your communication or 
nutrition or physical function as a result of participation in this research study.  You 
will receive personal health information such as your height and weight, physical 
function determined by a physical assessment, your blood lipids such as cholesterol 
and triglycerides.  In addition, you will receive information about your thinking skills 
and language skills and dietary choices. 
 
Drugs, devices or instruments to be used: 
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Drugs will not be used in this study. The equipment for the evaluations include: 
microphone, sound level meter, tongue blade, a digital tuner, tape recorder, and video 
cameras. All equipment used to collect cognitive-linguistic and physical function data 
is considered non-invasive. A lancet and capillary tube will be used to obtain the blood 
sample from a finger prick and the sample will be analyzed on a small portable 
machine that is on a table. 
  
Cost to participant: 
There is no cost to you for participation in the evaluations.  Parking is available for 
free. 
 
Confidentiality: 
Your part in this study is confidential.  Your individual privacy will be maintained in 
all published and written data resulting from this study.  No names of participants will 
be published or included in written data resulting from this study.  Results of this 
study may be used for purposes of research, educational lectures, and/or professional 
presentations.  When you are entered into the study you will be assigned a code that 
does not include any identifying information.  For example, the first participant will be 
coded as Long01.  The code number will be used on all response forms and in the 
analysis of the data.   
 
Dr. Mahler and her research team will have sole access to all contact information and 
evaluation results containing your name.  This information will be kept in a locked 
filing cabinet in a locked office.  However, the U.S. Department of Health and Human 
Services, and the University of Rhode Island Institutional Review Board have the right 
to inspect all of your records relating to this research for the purpose of verifying data.  
Because of the need to release information to these parties, absolute confidentiality 
cannot be guaranteed.  Following completion of this project, contact information will 
be destroyed for those participants who wish, for any reason, not to be contacted in the 
future.  All other information will be archived and kept in a locked filing cabinet with 
the study results at the University of Rhode Island.  All research data will be retained 
for a minimum of three years following completion of the study and then will be 
destroyed.  Research data will be located in a locked filing cabinet in the principal 
investigator’s locked office. 
 
Cognitive-linguistic evaluations will be audio and video recorded to allow for data 
analyses.  At times these recordings can be useful for teaching students or 
professionals about the disorders of people with a neurological diagnosis such as 
yours.  Please indicate by signing below whether you give your permission to use your 
samples for lectures and presentations.  Audio and/or videotapes may be used for 
teaching for up to 3 years after completion of the study.  If you agree, you will never 
be identified by name in the presentations or lectures.  Your decision to give 
permission to use audio and/or video samples in lectures has no impact on your 
participation in the study. 
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_____________________  Yes, I give permission to use audio samples in lectures and  
presentations. 
 
_____________________  Yes, I give permission to use video samples in lectures and  
presentations. 
 
______________________No, I do not want audio samples used except for research 
analysis. 
 
______________________No, I do not want video samples used except for research 
analysis. 
 
In case there is any injury to you during the study: 
If this study causes you any injury, you should immediately contact Dr. Leslie Mahler 
at (401) 874-2490 or contact the University of Rhode Island Speech and Hearing 
Clinic at (401) 874-5969.  You may also call the office of the Vice President for 
Research Integrity, 70 Lower College Road, University of Rhode Island, Kingston, RI 
at (401) 874-4328.  If you are injured during an evaluation or during treatment every 
effort will be made to get you medical attention but you will be responsible for paying 
for the medical treatment needed. 
 
Decision to quit at any time: 
The decision to take part in this study is up to you.  You do not have to participate.  If 
you decide to take part in the study, you may quit and stop participating in this study 
at any time. You have the right to refuse to answer any question(s) or participate in 
any procedure for any reason.  Deciding not to participate will have no effect on your 
potential to receive services from a speech-language pathologist.  If you wish to quit, 
simply inform Leslie Mahler at 874-2490 of your decision.  If you wish to pursue an 
alternative treatment instead of completing the study you will be provided with 
information on how to obtain those services. 
 
Rights and complaints: 
If you are not satisfied with the way this study is performed, you may discuss your 
complaints with Dr. Leslie Mahler (lmahler@uri.edu; 401-874-2490), Dr. Ingrid 
Lofgren (ingridlofgren@uri.edu, 401-874-5706), or Dr. Matthew Delmonico 
(delmonico@uri.edu; 401-874-5440), or you may contact the office of the Vice 
President for Research for concerns or any questions about your rights as a research 
subject at: 70 Lower College Road, University of Rhode Island, Kingston, RI at (401) 
874-4328 and speak to them anonymously if you choose. 
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Authorization: 
Your authorization means that you have read this paper and know the purpose of the 
study and the possible risks and benefits.  It also means you know that being in this 
study is voluntary and you choose to be in this study.  You can also withdraw at any 
time.  Your questions have been answered.  Your signature on this form means that 
you understand the information and you agree to participate in this study.  
 
 
 
 
________________________  ________________________ 
Signature of Participant   Signature of Researcher 
 
 
_________________________  ________________________ 
Participant Typed/printed Name  Researcher Typed/printed name 
 
 
__________________________  _______________________ 
Date      Date 
 
________________________  ________________________ 
Signature of Guardian    Signature of Researcher 
 
 
 
_________________________  ________________________ 
Guardian Typed/printed Name  Researcher Typed/printed name 
 
 
 
__________________________  _______________________ 
Date      Date 
 
 
Please sign both consent forms, keeping one for yourself. 
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Appendix D: Assessment Materials 
INTERVIEW 
Longitudinal Study of Communication, Nutrition and Physical 
Activity 
Leslie Mahler, PhD, CCC-SLP, Principal Investigator 
Ingrid Lofgren, PhD, co-Investigator 
Matthew Delmonico, PhD, co-Investigator 
Version 2: 2-17-14 
 
Participant Name:_________________________   Initials: ___  ___  ___  ID#:  ______________  
 
Name of Interviewer:_____________________________                    Date:_________________  
Emergency contact name and address & phone:     
                  
 _______________________________________ 
                  
 _______________________________________ 
               
DIRECTIONS:   Read the following questions out loud to each prospective 
volunteer and record the answers. Any answers that require clarification should be 
written in the space below the question or on the back of the sheet.  Indicate whether 
any follow-up is necessary or if any referrals are appropriate. 
 
What is your neurological diagnosis? __________________________ 
When were you diagnosed? _________________________________ 
What were your symptoms at that time? 
_____________________________________________________________________ 
What are your symptoms now?  
_____________________________________________________________________ 
What is your communication like?  
_____________________________________________________________________ 
What is your diet like? 
___________________________________________________________ 
What is your physical activity like? 
________________________________________________ 
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Does your speech sound clear to other people? 
_________________________________________ 
If not, how does it sound? 
___________________________________________________ 
Can you think of the words that you want to say? 
______________________________________ 
If you do have trouble, how often does it happen? 
 __________________________________ 
Are you experiencing any symptoms of a swallowing disorder? ____________ 
If yes, what is the problem with your swallowing? 
__________________________________ 
What would you say is your most significant problem with speech or swallowing 
today?________________________________________________________________
_________________________________________ 
Did you experience any changes in your speech or swallowing before your diagnosis? 
_____________________________________________________________________ 
Does medication affect your speech or voice or swallowing? _________ 
If yes, in what way? _____________________________________________ 
 
Speech 
How many hours of speaking do you do in a day? _________________________ 
What is a typical day of communicating like for you? 
_____________________________________________________________________
_____________________________________________________________________ 
Do you pronounce your words clearly? 
____________________________________________ 
Do people ask you to repeat yourself? 
______________________________________________ 
Do people have a hard time understanding you? 
______________________________________ 
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What do you do when you want to be as easy to understand as possible?  
_____________________________________________________________________
_____________________________________________________________________ 
What percent of your speech do you think is understandable? 
_____________________________________________________________________ 
Has your neurological diagnosis caused you to talk less? 
_____________________________________________________________________ 
If so, how much less? ___________ Why?__________________________________ 
_____________________________________________________________________ 
 
Swallowing 
Do you have any difficulty with swallowing? 
___________________________________ 
Do you cough during mealtimes? _____________________ 
If yes, do you cough more with water or solid food? _________________ 
Do you have difficulty making the food go down (need to swallow twice)? 
________________________________________________________________ 
Does it take you longer to finish a meal than before your neurological diagnosis? 
__________________________________________________________ 
Have you experienced any unintentional recent weight loss? _____________ 
Have you ever been diagnosed with pneumonia? ____________  
If yes, when? _____________ 
Have you changed your diet since your neurological 
diagnosis?___________________ 
If yes, what did you modify? ___________________________________ 
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Musculoskeletal system: 
Has your doctor ever told you that you have:  (circle all that apply) 
 Osteoarthritis or degenerative arthritis                                                                
 Rheumatoid arthritis                                                                                            
 Osteoporosis                         
 Ankylosing Spondylitis                                                                                       
 Unknown or other type of arthritis                                                                      
 Any other disease of joint or muscle: 
 Comments:          
Cardiovascular system: 
 Has any family member had a heart attack prior to the age of 55?          
o If so, how are they related to you?                     
 Have you ever had frequent cramping in your legs while resting?                      
o If yes, is it a current problem?        _____________________________                                     
 Have you ever had pain or cramping in your legs while walking?                         
o If yes, is it a current problem?     ________________________________                                       
  If yes, is this pain relieved by rest or by discontinuing walking?___________ 
 Have you ever been told that you have high blood pressure 
o If yes, what was the date of onset? ____________________ 
o Were you given any medications?       ______________                                                      
 Did a doctor ever tell you that you had a heart problem?                                      
o If yes: What was the date of onset? _______________________ 
 What did the doctor call it? _________________________________ 
o Were you given any medications?   ____________________________  
   Do you have any history of high cholesterol in your blood as evidenced by  a 
previous blood lipid tests?
 ________________________________________________________ 
Comments:___________________________________________________ 
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Endocrine system: 
Have you ever had any of the following: Thyroid problems, adrenal problems, 
diabetes mellitus? 
 ____________________________________________________________
  
 If yes to diabetes, which type? Type 1 or Type 2   
  
  Date of onset- _________________________ 
Are/were you on any medication, or is it diet controlled? 
____________________________________________________________ 
Neurological system: 
 Do you have any significant problems with your memory? (circle all that apply) 
o When answering the telephone, do you recall what you were doing 
before it rang?           
o Can you give the directions to your house/apartment?  
o Can you keep appointments without a reminder? 
o Can you remember what clothes you wore yesterday?                     
 Any problems with vision other than corrective lens changes?                     
o If yes, which of the following conditions- Blindness, temporary loss    
of vision, double vision, glaucoma, cataract, macular degeneration or 
others. 
_________________________________________________________ 
Do you have and of the following?: (circle all that apply) 
 Vertigo (a feeling of spinning, or unsteadiness)                
 Seizure or convulsions?    
 Migraine or severe headaches?                         
 Paralysis of arm or leg?                                     
 A head injury with loss of consciousness?     
 Pain, numbness or tingling in your limbs?             
 Pain in your lower back?  
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 Do you have pain in any part of body including headaches while exercising?
                                
 Have you been told that you have a peripheral neuropathy?                   
 Tremors?                                    
 Problems with walking? If yes, 
o Do you fall frequently?                        
o Is your walking problem related to pain, weakness or loss of balance?  
                         
 Have you ever had an operation on skull or brain?    
       
 Have you ever had meningitis or Brain fever?          
Comments:          
 
Previous Treatment 
Have you had previous speech or swallow treatment, occupational therapy or physical 
therapy? _____________________________________________________________ 
If yes, please describe (when, what) 
_____________________________________________________________________ 
_____________________________________________________________________ 
Was it beneficial? 
_____________________________________________________________________ 
If yes, what changes did you notice? 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Employment 
Are you employed? 
___________________________________________________________ 
Type of employment 
__________________________________________________________ 
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How much speaking do you do at your job? 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Smoking Status  
Do you currently smoke cigarettes? ___________________________ 
Do you have a history of smoking cigarettes? ___________________ 
If you have quit smoking cigarettes, how many months/years ago did you quit? 
___________________ 
 
Other 
Have you noticed any difficulty with your memory? 
_____________________________ 
Have you experienced any changes in your mood? 
_______________________________ 
Is it difficult for you to pay attention long enough to finish a task? 
___________________ 
Do you have any difficulty reading? ____________________________________ 
Do you have any difficulty writing? ___________________________________ 
Do you have any other health problems or conditions that would affect 
communication, nutrition or physical activity? 
____________________________________________________________________ 
 
Are you Hispanic or Latino? _______  
What race do you identify with?  (Check all that apply) ______ I prefer not to provide 
this information 
White/Caucasian ______ African American_______ Asian _______American 
Indian/Alaskan Native______ Native Hawaiian/Pacific Islander_______ 
Other_______  
Dietary Screening Tool 
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DIRECTIONS: Please check one response to each question that best 
describes how you eat.  
 
 
How often do you usually eat fruit as a snack? 
____ Never  
____ Less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you usually eat whole grain breads? 
____  Never or less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you usually eat whole grain cereals? 
____  Never or less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you usually eat candy or chocolate? 
____  Never  
____ Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat crackers, pretzels, chips, or popcorn? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat cakes or pies? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
 
 
How often do you eat cookies? 
____  Never  
____  Less than once a week 
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____  1 or 2 times a week 
____  3 or more times a week 
 
 
How often do you eat ice cream? 
____  Never  
____  Less than once a week 
____  1 or 2 times a week 
____  3 or more times a week 
 
How often do you eat cold cuts, hot dogs, lunchmeats or deli 
meats? 
____ Never  or less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat bacon or sausage? 
____ Never  or less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat carrots, sweet potatoes, broccoli, or 
spinach? 
____ Never  
____ Less than once a week 
____ 1 or 2 times a week 
____ 3 or more times a week 
 
How often do you eat fruit (not including juice)? Please 
include fresh, canned or frozen fruit. 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
  
 
 
 
 
 
  
How often do you eat hot or cold breakfast cereal? 
____  Never  
____  Less than once a week 
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____  1 or 2 times a week 
____ 3 to 5 times a week 
____  Every day or almost every day  
 
 
How often do you drink some kind of juice at breakfast? 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
 
How often do you eat chicken or turkey? 
____ Never or less than once a week 
____ 1 or 2 times a week 
____ More than 3 times a week 
 
 
How often do you drink a glass of milk? 
____ Never or Less than once a week 
____ 1 or 2 times a week 
____ 3 to 5 times a week 
____ Every day or almost every day  
____ More than once every day 
 
 
Do you usually add butter or margarine to foods like bread, 
rolls, or biscuits? 
____ Yes   
____ No 
 
Do you usually add fat (butter, margarine or oil) to potatoes 
and other vegetables? 
____ Yes   
____ No 
 
Do you use gravy (when available) at meals? 
____ Yes   
____ No 
 
 
Do you usually add sugar or honey to sweeten your coffee or 
tea? 
____ Yes   
____ No 
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Do you usually drink wine, beer or other alcoholic 
beverages? 
____ Yes   
____ No 
 
How often do you eat fish or seafood that IS NOT fried? 
____ Never  
____ Less than once a week 
____ Once a week 
____ More than once a week  
 
How many servings of milk, cheese, or yogurt do you usually 
have each DAY? 
____ None  
____ One  
____ Two or more  
 
How many different vegetable servings do you usually have 
at your main meal of the day?  
____ None  
____ One  
____ Two  
____ Three or more 
 
 
Which of the following best describes your nutritional 
supplement use. 
____  I don’t use supplements  
____  I use supplements other than vitamins and mineral 
____  I use a multivitamin/mineral preparation (e.g. Centrum) 
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